Volume depletion

E4_VOLUME

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E86 Hospital discharge: ICD-9 — 2765 Hospital discharge: ICD-8 — 7880 Cause of death: ICD-10 — E86 Cause of death: ICD-9 — 2765 Cause of death: ICD-8 — 7880 2 out of 7 registries used, show all original rules.	3838
4. Check minimum number of events None	3838
5. Include endpoints None	3838
6. Filter based on genotype QC (FinnGen only)	3838

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Depletio voluminis liquoris

NAME	E4_VOLUME
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E86
HD_ICD_9	2765
HD_ICD_8	7880
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E86
COD_ICD_9	2765
COD_ICD_8	7880
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Volume depletion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	44655	24590	19806
Only index persons	37185	20583	16602
Unadjusted period prevalence (%)
Whole population	0.63	0.70	0.55
Only index persons	0.70	0.76	0.63
Median age at first event (years)
Whole population	77.57	81.19	73.09
Only index persons	77.71	81.39	73.15

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3838	1716	2122
Unadjusted period prevalence (%)	0.78	0.58	0.94
Median age at first event (years)	72.87	72.14	73.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3440: Matched controls
34397

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E86

ICD-10 Finland

Volume depletion

4503599627370496.0

323.0

3357

N17.9

ICD-10 Finland

Acute renal failure, unspecified

13.1

322.4

599

545

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

55.1

294.7

352

R53

ICD-10 Finland

Malaise and fatigue

4.2

264.5

1265

4156

C03CA01

ATC

furosemide; systemic

3.4

237.7

1824

8654

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

4.3

228.5

1009

3002

E87.6

ICD-10 Finland

Hypokalaemia

45.1

224.1

278

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.9

212.4

1071

3560

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.4

185.8

776

2134

AA1AD

NOMESCO Finland

CT of head and brain

3.3

182.3

1214

4923

E87.5

ICD-10 Finland

Hyperkalaemia

51.8

181.4

219

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.8

176.8

887

2866

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

162.1

1800

9955

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.6

157.1

850

2887

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

152.1

1365

6567

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.3

149.1

495

1049

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

4.6

146.5

566

1411

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

145.3

975

3859

A28

ICPC

Limited function/disability NOS

3.2

141.3

928

3605

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

139.1

1261

6025

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

132.6

2240

14872

C07AB07

ATC

bisoprolol; oral

2.4

131.0

1958

12168

N05AH04

ATC

quetiapine; oral

3.3

128.7

749

2642

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

8.4

127.9

296

381

R11

ICD-10 Finland

Nausea and vomiting

4.4

126.4

510

1315

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.2

125.1

794

2975

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.0

124.1

562

1611

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.4

123.4

402

825

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

122.0

681

2316

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.0

118.6

536

1529

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

116.8

830

3340

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.6

116.6

445

1081

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

115.0

635

2133

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

114.6

1358

7327

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

111.2

969

4405

C03DA01

ATC

spironolactone; oral

3.3

111.0

633

2174

SPAT1254

SPAT

Administration of medicine

2.9

110.7

791

3178

N02AA05

ATC

oxycodone; systemic

2.9

110.6

800

3241

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.6

109.2

1047

5017

A10AE04

ATC

insulin glargine; parenteral

3.9

108.6

498

1432

SPAT1262

SPAT

Handing over of treatment supplies

2.8

106.3

822

3464

A02BC02

ATC

pantoprazole; systemic

2.2

105.7

2247

15756

N19

ICD-10 Finland

Unspecified kidney failure

6.3

105.6

300

517

N02BE01

ATC

paracetamol; systemic, rectal

2.6

103.7

2906

23217

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

103.3

1164

6040

N06AX11

ATC

mirtazapine; oral

2.4

102.9

1199

6325

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

97.8

717

2902

L28

ICPC

Limited function/disability (L)

2.7

96.0

781

3366

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.4

92.7

361

886

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.7

91.1

439

1306

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.5

90.6

471

1489

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.5

90.0

343

823

J01MA02

ATC

ciprofloxacin; systemic

2.1

89.6

1516

9339

I50.0

ICD-10 Finland

Congestive heart failure

3.2

88.1

530

1867

JN3AD

NOMESCO Finland

Abdominal CT examination

3.9

87.9

397

1115

A06AD11

ATC

lactulose; oral

2.5

85.5

814

3800

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

85.2

779

3555

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

85.1

834

3951

E87.2

ICD-10 Finland

Acidosis

+∞

84.7

UJF32

NOMESCO Finland

Coloscopy

2.3

84.4

1008

5274

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.6

83.8

311

725

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

81.0

667

2861

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

80.3

483

1693

R50.9

ICD-10 Finland

Fever, unspecified

2.7

79.8

639

2693

SPAT1216

SPAT

Assessment of functional ability

2.5

79.5

753

3486

T90

ICPC

Diabetes non-insulin dependent

2.3

78.9

869

4348

M04AA01

ATC

allopurinol; systemic

2.6

78.7

671

2929

R06.0

ICD-10 Finland

Dyspnoea

2.2

78.4

984

5235

SPAT1229

SPAT

Assessment of need for aid

3.2

77.4

443

1496

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.2

77.1

999

5384

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.1

76.6

477

1710

R55

ICD-10 Finland

Syncope and collapse

2.8

76.5

566

2269

SPAT1301

SPAT

No procedures

2.1

76.2

1233

7310

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.0

75.6

330

895

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.8

75.5

225

409

A04

ICPC

Weakness/tiredness general

2.7

75.4

605

2545

N30.0

ICD-10 Finland

Acute cystitis

2.6

74.7

619

2652

N05AX08

ATC

risperidone; systemic

3.1

74.4

464

1662

A46

ICD-10 Finland

Erysipelas

2.5

72.4

647

2886

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.8

72.0

172

230

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

71.8

1239

7496

N05BA04

ATC

oxazepam; oral

2.2

71.6

945

5107

N18.8

ICD-10 Finland

Other chronic renal failure

6.1

71.3

203

348

I95.1

ICD-10 Finland

Orthostatic hypotension

4.6

70.9

262

606

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

70.1

1185

7093

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

16.9

69.9

113

N17.8

ICD-10 Finland

Other acute renal failure

12.1

69.3

129

110

SPAT1263

SPAT

Sampling

1.9

69.1

1470

9591

J01DB01

ATC

cefalexin; oral

2.0

69.1

2622

21106

C08CA01

ATC

amlodipine; oral

2.0

69.1

1330

8362

N05AH03

ATC

olanzapine; systemic

4.4

68.8

269

657

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

68.2

371

1202

A10BA02

ATC

metformin; oral

2.0

67.4

1070

6221

R41.0

ICD-10 Finland

Disorientation, unspecified

4.8

67.1

239

531

C09AA05

ATC

ramipril; oral

2.1

66.5

1002

5697

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.5

66.1

571

2490

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

65.7

1117

6657

A41.9

ICD-10 Finland

Sepsis, unspecified

4.4

65.5

252

606

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

65.0

333

1029

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.9

64.0

166

251

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

63.8

725

3626

S97

ICPC

Chronic ulcer skin

3.7

63.5

303

883

J01MA12

ATC

levofloxacin; systemic

2.2

62.9

750

3833

N03AX16

ATC

pregabalin; oral

2.1

62.9

825

4405

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

62.4

404

1475

N05CF01

ATC

zopiclone; oral

1.9

62.1

1253

7925

I95.9

ICD-10 Finland

Hypotension, unspecified

8.0

61.7

145

189

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.9

61.5

160

243

N02AX02

ATC

tramadol; systemic, rectal

1.9

61.2

1462

9804

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

60.5

401

1485

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.5

60.2

228

539

A10BH05

ATC

linagliptin; oral

3.9

60.2

265

721

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

598.1

59.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

59.8

1024

6077

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

59.5

970

5643

B01AC04

ATC

clopidogrel; oral

2.4

59.1

602

2845

M10.9

ICD-10 Finland

Gout, unspecified

3.3

59.1

327

1069

N06AB04

ATC

citalopram; systemic

2.1

58.8

774

4121

C10AA01

ATC

simvastatin; oral

1.8

58.5

1522

10452

G72.8

ICD-10 Finland

Other specified myopathies

7.7

58.5

140

188

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

58.1

522

2310

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

58.1

441

1774

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.5

58.1

219

515

N03AG01

ATC

valproic acid; systemic, rectal

3.7

58.0

268

759

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.1

57.9

146

212

SPAT1234

SPAT

Support of social functional capacity

3.4

57.6

306

970

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

57.0

298

933

R4110

NOMESCO Finland

Physiotherapy

2.0

56.9

903

5182

A11CC03

ATC

alfacalcidol; systemic

6.9

56.9

147

221

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

56.4

300

951

WX892

NOMESCO Finland

Monitored bed care

3.1

56.3

331

1129

R42

ICD-10 Finland

Dizziness and giddiness

2.0

55.6

831

4650

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.8

55.5

381

1440

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.1

54.9

778

4254

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.7

54.0

161

292

TK800

NOMESCO Finland

Hemodialysis

6.8

54.0

141

215

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

11.8

53.8

101

R33

ICD-10 Finland

Retention of urine

2.6

53.5

421

1727

R60.0

ICD-10 Finland

Localized oedema

2.5

53.2

474

2083

A10BH01

ATC

sitagliptin; oral

2.7

52.7

393

1558

A10AE05

ATC

insulin detemir; parenteral

3.6

52.1

254

751

F05.9

ICD-10 Finland

Delirium, unspecified

5.6

51.9

157

290

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.3

51.7

538

2554

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

51.6

363

1390

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.8

51.6

181

395

S06.0

ICD-10 Finland

Concussion

2.6

51.3

415

1727

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

51.2

734

4017

C10AA05

ATC

atorvastatin; oral

1.8

51.0

1187

7753

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

50.7

464

2065

ZX120

NOMESCO Finland

Intravenous

2.7

50.0

382

1537

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

49.7

658

3477

H02AB06

ATC

prednisolone; systemic

1.7

49.6

1543

11008

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

49.6

879

5213

B01AB05

ATC

enoxaparin; parenteral

1.9

49.6

1021

6386

N30.9

ICD-10 Finland

Cystitis, unspecified

3.2

49.5

285

953

N05CD07

ATC

temazepam; oral

2.2

49.4

603

3078

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.2

49.4

277

909

B01AA03

ATC

warfarin; systemic

1.9

49.4

972

5984

N05AA02

ATC

levomepromazine; systemic

3.9

49.3

215

579

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

47.8

234

694

AN1

Coronary angiography

2.4

47.5

463

2120

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.9

47.4

204

543

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

4.6

47.3

170

381

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

11.7

46.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

46.1

331

1280

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.9

46.0

100

115

C09AA02

ATC

enalapril; systemic

1.9

45.9

826

4904

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.8

45.8

160

348

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.2

45.6

547

2760

B03BA03

ATC

hydroxocobalamin; parenteral

2.8

45.2

312

1178

B03XA02

ATC

darbepoetin alfa; parenteral

6.5

44.9

121

193

2765A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Volume depletion

+∞

44.9

K92.1

ICD-10 Finland

Melaena

3.1

44.8

271

936

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

44.4

276

974

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

43.9

1061

6935

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.1

43.7

180

460

SPAT1260

SPAT

Consultation of another employee

2.0

43.4

615

3326

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

43.1

842

5124

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

43.1

372

1595

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

42.8

218

666

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

42.6

408

1848

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

42.5

256

884

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

42.2

312

1227

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.4

42.2

131

250

SPAT1255

SPAT

Intravenous administration of medicine

2.8

42.0

284

1057

P15

ICPC

Chronic alcohol abuse

5.6

41.8

126

232

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.9

41.8

180

479

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

41.8

565

2994

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.8

41.7

185

505

N06AX16

ATC

venlafaxine; oral

2.4

41.4

381

1688

C01DA14

ATC

isosorbide mononitrate; oral

1.9

41.2

716

4175

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

41.1

368

1607

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.3

40.7

215

675

N05BA01

ATC

diazepam; systemic, rectal

2.1

40.7

497

2518

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

40.7

598

3272

V03AE01

ATC

polystyrene sulfonate; oral

7.7

40.4

128

205

Kela drug reimbursment

Chronic hypertension

1.7

40.4

1141

7775

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

40.3

615

3411

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

40.2

687

3976

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

40.1

288

1112

W19

ICD-10 Finland

Unspecified fall

2.3

40.1

396

1820

Z51.5

ICD-10 Finland

Palliative care

2.7

39.8

287

1111

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.8

39.6

122

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

39.4

936

6040

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

39.2

231

785

B01AB10

ATC

tinzaparin; parenteral

2.9

39.0

259

952

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

14.6

39.0

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

22.7

38.8

N05AX12

ATC

aripiprazole; systemic

5.0

38.7

128

263

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.2

38.6

123

242

Z93.2

ICD-10 Finland

Ileostomy status

30.4

38.3

JAH00

NOMESCO Finland

Laparotomy

4.2

38.3

151

371

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

38.1

1311

9394

A12AA04

ATC

calcium carbonate; oral

6.8

37.9

148

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.7

37.9

269

1031

N18.0

ICD-10 Finland

End-stage renal disease

7.6

37.7

121

I20.09

ICD-10 Finland

Unstable angina

2.9

37.7

250

916

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.6

37.6

113

208

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

14.9

37.6

78800

ICD-8 Finland

Other general symptoms, Electrolyte disorders

+∞

37.6

SPAT1167

SPAT

Insertion of urinary catheter

3.4

37.2

193

598

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

15.0

37.1

N06AX21

ATC

duloxetine; oral

2.5

37.1

318

1356

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

15.5

37.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

36.9

796

4969

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.8

36.9

143

T89

ICPC

Diabetes insulin dependent

4.2

36.8

144

351

127

Kela drug reimbursment

Transplant complication

7.8

36.6

113

UKC02

NOMESCO Finland

Cystoscopy

1.9

36.6

642

3736

L04AA06

ATC

mycophenolic acid; systemic

7.5

36.6

120

E66.00

ICD-10 Finland

Metabolic syndrome

3.6

36.6

175

509

JN4AD

NOMESCO Finland

Body CT examination

2.6

36.3

295

1219

N03AX09

ATC

lamotrigine; oral

4.0

36.3

150

385

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

9.1

36.2

Z94.0

ICD-10 Finland

Kidney transplant status

9.6

36.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

36.0

279

1125

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.3

35.9

190

598

N05AH02

ATC

clozapine; systemic

7.8

35.9

110

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.4

35.6

179

541

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

35.6

1321

9606

L04AX01

ATC

azathioprine; systemic

3.5

35.6

176

525

N06AB10

ATC

escitalopram; oral

2.0

35.5

535

2939

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.5

35.3

108

203

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.3

35.3

136

327

E0000UV

ATC

1.6

35.0

1168

8251

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.4

35.0

132

311

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

34.9

242

911

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

34.9

412

2049

C07AB02

ATC

metoprolol; systemic

1.7

34.9

826

5291

F10.24

ICD-10 Finland

Alcohol depence active use

7.9

34.8

105

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

8.5

34.8

E83.51

ICD-10 Finland

Hypocalcemia

96.0

34.8

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.0

34.7

167

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.1

34.7

112

224

S01.0

ICD-10 Finland

Open wound of scalp

2.4

34.6

315

1385

JN4BD

NOMESCO Finland

Extensive body CT

2.1

34.6

414

2072

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

34.4

527

2914

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.9

34.4

169

J01EA01

ATC

trimethoprim; systemic

1.7

34.1

869

5685

SPAT1252

SPAT

Overall medication plan or its review

2.4

34.0

304

1321

K59.1

ICD-10 Finland

Functional diarrhoea

3.1

34.0

195

650

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

34.0

743

4638

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.7

34.0

157

444

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

12.6

34.0

J01FF01

ATC

clindamycin; systemic

1.7

33.8

815

5244

A10BB12

ATC

glimepiride; oral

2.3

33.6

336

1548

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

33.6

234

884

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.5

33.5

272

1123

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.5

33.4

123

283

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.6

33.3

134

H02AB09

ATC

hydrocortisone; systemic

5.0

33.3

109

222

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

33.1

1402

10483

P01AB01

ATC

metronidazole; oral, rectal

1.6

33.1

1082

7579

I50

ICD-10 Finland

Heart failure

3.1

32.9

186

613

C02AC05

ATC

moxonidine; oral

3.2

32.8

181

587

N05AN01

ATC

lithium; oral

5.1

32.6

105

210

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

10.5

32.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.0

32.5

200

700

137

Kela drug reimbursment

Uraemia requiring dialysis

11.7

32.3

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.8

32.3

163

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

32.2

195

674

J01MA14

ATC

moxifloxacin; systemic

2.3

31.8

316

1448

SPAT1251

SPAT

Organisation of medication

3.0

31.6

189

648

ZXA00

NOMESCO Finland

Right side

1.7

31.6

902

6073

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.3

31.3

315

1452

N07BB01

ATC

disulfiram; oral

3.6

31.3

147

422

Z49.2

ICD-10 Finland

Other dialysis

13.7

31.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.6

31.1

171

ZXA05

NOMESCO Finland

Left side

1.7

31.0

855

5696

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.4

31.0

282

1237

C10AC01

ATC

colestyramine; oral

4.3

30.8

118

283

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

30.7

297

1343

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.3

30.6

B01AF02

ATC

apixaban; oral

2.1

30.5

372

1871

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.8

30.3

152

A01

ICPC

Pain general/multiple sites

2.4

30.3

273

1193

A02BC01

ATC

omeprazole; systemic

1.6

30.2

934

6411

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.3

30.0

157

490

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.4

29.9

150

453

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.2

29.8

103

P20

ICPC

Memory disturbance

1.9

29.6

515

2966

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

29.3

1166

8513

207

Kela drug reimbursment

Chronic arrhythmias

1.8

29.3

576

3457

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

29.2

341

1683

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

14.6

29.2

E83.50

ICD-10 Finland

Hypercalcemia

14.6

29.2

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

29.2

205

779

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.1

29.1

103

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

9.2

29.1

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.1

29.0

116

290

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

28.9

563

3367

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.2

28.9

178

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

28.9

551

3272

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

28.8

240

1006

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

17.5

28.8

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.3

28.7

M54.5

ICD-10 Finland

Low back pain

1.6

28.6

878

5999

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

28.4

161

530

JFF10

NOMESCO Finland

Loop enterostomy

10.3

28.4

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

4.0

28.3

116

296

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.7

28.3

149

N05AF03

ATC

chlorprothixene; systemic

4.3

28.3

108

258

Z00.8

ICD-10 Finland

Other general examinations

2.5

28.3

234

976

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

11.4

28.3

R4190

NOMESCO Finland

Nutritional therapy

3.7

28.2

128

357

B05DB

ATC

Hypertonic solutions

14.9

28.2

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.9

28.2

118

307

K51.5

ICD-10 Finland

Left sided colitis

4.4

28.2

105

245

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.8

28.1

122

328

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

28.1

245

1053

S18

ICPC

Laceration/cut

1.5

28.0

1249

9340

A04AA01

ATC

ondansetron; systemic, rectal

2.5

28.0

229

949

B05DA

ATC

Isotonic solutions

13.1

27.9

J01DA01

ATC

[U] cefalexin; systemic

1.5

27.8

1909

15675

N06AB06

ATC

sertraline; oral

2.2

27.8

294

1386

N03AX12

ATC

gabapentin; oral

1.9

27.7

449

2520

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

27.6

453

2550

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.5

27.6

229

954

SPAT1125

SPAT

Stoma care and guidance

4.3

27.6

104

246

F03

ICD-10 Finland

Unspecified dementia

2.3

27.4

267

1209

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

27.4

343

1739

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

10.3

27.4

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

27.3

363

1887

SPAT1139

SPAT

Nutrition survey

3.2

27.3

146

464

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.2

27.2

300

1440

M79.6

ICD-10 Finland

Pain in limb

1.6

27.2

972

6889

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

27.2

914

6379

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

27.1

360

1874

K08.3

ICD-10 Finland

Retained dental root

2.4

27.1

238

1025

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

27.1

285

1342

A29

ICPC

General symptom/complaint other

2.0

27.0

387

2075

K77

ICPC

Heart failure

3.7

27.0

121

335

R51.80

ICD-10 Finland

Headache

2.0

26.9

378

2009

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

26.9

867

5984

WX730

NOMESCO Finland

Conventional respirator

4.7

26.9

202

H04AA01

ATC

glucagon; nasal, parenteral

4.9

26.8

185

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

18.0

26.5

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.0

26.5

174

A07EC02

ATC

mesalazine; oral, rectal

2.8

26.5

182

683

F34.1

ICD-10 Finland

Dysthymia

4.0

26.4

108

276

SPAT1172

SPAT

Guidance concerning hydration

3.3

26.3

140

443

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

26.3

526

3165

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

16.3

26.2

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.3

26.2

135

417

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

26.2

138

434

P29

ICPC

Psychological sympt/compl other

3.0

26.1

157

541

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

26.1

331

1687

JFF13

NOMESCO Finland

Terminal enterostomy

21.3

26.0

C03AA03

ATC

hydrochlorothiazide; oral

2.0

26.0

363

1923

K92.0

ICD-10 Finland

Haematemesis

3.3

25.7

133

412

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.2

25.7

278

1323

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.8

25.7

173

642

I50.1

ICD-10 Finland

Left ventricular failure

2.3

25.6

239

1061

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.8

25.6

110

294

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

25.5

179

680

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.6

25.4

116

326

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.8

25.3

129

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

25.3

202

826

P16

ICPC

Acute alcohol abuse

6.0

25.2

118

Angiography of the heart and coronary arteries

2.2

25.1

278

1338

A07AA09

ATC

vancomycin; oral

5.3

25.1

151

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

25.1

609

3885

N06AA09

ATC

amitriptyline; systemic

2.0

25.1

326

1680

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

12.3

25.0

WX882

NOMESCO Finland

High dependency care

3.4

24.9

124

374

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

24.9

218

937

J01CA08

ATC

pivmecillinam; oral

1.5

24.9

1087

8037

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

24.7

332

1734

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.8

24.7

U04

ICPC

Incontinence urine

2.6

24.7

192

774

EBA00

NOMESCO Finland

Extraction of tooth

1.6

24.6

899

6375

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.7

24.6

109

299

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.5

24.6

205

859

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

24.6

449

2619

WX872

NOMESCO Finland

Intensive care

2.8

24.5

169

633

C08CA13

ATC

lercanidipine; oral

1.8

24.5

426

2444

R31

ICD-10 Finland

Unspecified haematuria

1.9

24.3

379

2094

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

24.3

1209

9182

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

8.8

24.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

24.2

250

1163

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.2

24.2

269

1296

N06DX01

ATC

memantine; oral

2.0

24.1

333

1755

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

24.1

1056

7800

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

24.1

125

389

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

15.7

24.1

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.1

23.9

285

1416

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.3

23.8

139

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

23.8

170

654

A41.8

ICD-10 Finland

Other specified sepsis

4.1

23.7

229

WW500

NOMESCO Finland

Blood transfusion

2.8

23.7

156

569

RS220

NOMESCO Finland

5.7

23.7

124

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.8

23.6

V03AE02

ATC

sevelamer; oral

17.0

23.5

A07EA06

ATC

budesonide; oral, local oral

3.5

23.4

114

338

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

23.4

432

2528

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

23.4

264

1282

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.1

23.3

147

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

23.3

213

936

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.8

23.2

169

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.1

23.2

148

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

23.1

187

772

TK820

NOMESCO Finland

Peritoneal dialysis

18.6

23.0

I20.00

ICD-10 Finland

Unstable angina

2.9

23.0

145

517

K59.0

ICD-10 Finland

Constipation

2.3

23.0

227

1036

Z72.1

ICD-10 Finland

Alcohol use

5.7

22.9

117

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

8.2

22.8

M10

ICD-10 Finland

Gout

2.7

22.8

159

600

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

22.8

258

1254

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.7

22.8

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

22.8

102

283

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

22.7

252

1211

SPAT1240

SPAT

Therapeutic discussion

2.2

22.7

252

1213

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.4

22.6

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

231.4

22.6

S70.0

ICD-10 Finland

Contusion of hip

2.7

22.5

161

618

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.5

22.5

106

307

J01CA04

ATC

amoxicillin; systemic

1.4

22.4

2333

20372

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.0

22.3

130

440

N06AB03

ATC

fluoxetine; oral

1.9

22.3

338

1844

SPAT1053

SPAT

Memory test

1.7

22.2

572

3698

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

22.1

268

1338

R04.0

ICD-10 Finland

Epistaxis

2.1

22.1

270

1352

K56.7

ICD-10 Finland

Ileus, unspecified

3.9

22.1

240

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

22.1

252

1227

N05AB03

ATC

perphenazine; systemic, rectal

3.1

22.0

125

413

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

22.0

165

651

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.1

21.9

267

1338

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.2

21.9

132

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.9

21.9

237

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.5

21.8

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

13.8

21.7

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.9

21.7

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

18.5

21.7

A12BA01

ATC

potassium chloride; oral

2.1

21.7

245

1189

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.4

21.7

106

316

R03BB04

ATC

tiotropium bromide; inhalant

1.8

21.7

377

2158

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.7

21.6

160

R13

ICD-10 Finland

Dysphagia

2.2

21.6

220

1018

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.8

21.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

21.5

126

429

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

7.0

21.4

RD210

NOMESCO Finland

4.2

21.3

199

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

21.3

688

4712

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.5

21.2

175

731

WZC30

NOMESCO Finland

Teaching

1.8

21.1

362

2060

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.4

21.1

182

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

21.0

544

3513

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.0

21.0

221

E000001

ATC

1.6

21.0

600

3982

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.3

20.9

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.2

20.8

127

SPAT1101

SPAT

Orthostatic test

2.3

20.8

197

881

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

21.6

20.8

R02

ICPC

Shortness of breath/dyspnoea

1.8

20.8

359

2051

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.1

20.7

116

383

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.3

20.7

193

855

I95.2

ICD-10 Finland

Hypotension due to drugs

7.0

20.6

WX110

NOMESCO Finland

Local anesthesy

1.4

20.6

1809

15168

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.3

20.6

107

334

I95.8

ICD-10 Finland

Other hypotension

13.0

20.6

N05AD01

ATC

haloperidol; systemic

2.7

20.6

147

566

B81

ICPC

Anaemia vit B12/folate deficiency

2.6

20.6

153

601

F31

ICD-10 Finland

Bipolar affective disorder

7.6

20.6

H03AA01

ATC

levothyroxine sodium; systemic

1.6

20.6

628

4233

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.0

20.5

286

1513

R03AC02

ATC

salbutamol; inhalant

1.4

20.4

1432

11519

P76

ICPC

Depressive disorder

2.7

20.4

145

555

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

7.5

20.4

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.5

20.3

G04CA02

ATC

tamsulosin; oral

1.5

20.3

866

6313

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

20.2

185

815

A99

ICPC

Disease/condition unspecnature/site

2.0

20.1

253

1285

K65.0

ICD-10 Finland

Acute peritonitis

5.0

20.0

129

F01.9

ICD-10 Finland

Vascular dementia, unspecified

3.4

20.0

100

304

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.5

20.0

156

630

SPAT1211

SPAT

Application of soft bandage

1.9

19.9

293

1581

A10BJ02

ATC

liraglutide; parenteral

4.4

19.9

165

JFH10

NOMESCO Finland

Total colectomy and ileostomy

20.9

19.9

P99

ICPC

Psychological disorders other

4.0

19.9

208

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

19.9

177

768

S20.2

ICD-10 Finland

Contusion of thorax

2.5

19.8

162

672

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

19.8

129

469

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

19.8

198

909

Z71.8

ICD-10 Finland

Other specified counselling

1.6

19.8

603

4063

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.6

19.8

254

G47.3

ICD-10 Finland

Sleep apnoea

1.7

19.7

495

3164

H3603, E103

ICD-10 Finland

7.3

19.7

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.3

19.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

19.7

532

3473

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

19.6

136

513

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.2

19.6

200

928

N06AA12

ATC

doxepin; systemic

2.3

19.5

191

867

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.4

19.5

175

762

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.8

19.5

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

19.5

220

1068

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.2

19.4

105

338

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.4

19.4

295

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

6.4

19.4

JFB00

NOMESCO Finland

Partial resection of small intestine

4.0

19.4

198

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

19.4

916

6808

K90

ICPC

Stroke/cerebrovascular accident

2.9

19.4

118

412

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

19.4

101

317

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.9

19.3

130

EBA30

NOMESCO Finland

Excision of root of tooth

2.3

19.2

176

774

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

19.2

148

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

19.2

138

532

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

11.8

19.2

A07AA02

ATC

nystatin; oral

2.1

19.2

218

1061

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

19.2

298

1640

N03AE01

ATC

clonazepam; systemic

2.3

19.1

180

801

SPAT1104

SPAT

Monitoring of emergency patient

2.1

19.1

228

1132

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

19.1

205

972

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

19.0

210

1009

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

18.9

449

2827

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.3

18.9

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.9

18.9

116

407

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

18.9

240

1220

A10AE06

ATC

insulin degludec; parenteral

3.5

18.9

259

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.9

18.8

125

L17

ICPC

Foot/toe symptom/complaint

1.5

18.8

681

4775

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.5

18.8

152

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

18.8

133

511

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

18.8

133

511

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.9

18.7

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

18.7

998

7595

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

2.2

18.6

195

915

H36.01

ICD-10 Finland

Diabetic maculopathy

5.2

18.6

114

C09CA01

ATC

losartan; oral

1.5

18.6

704

4984

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

18.6

276

1493

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.5

18.5

154

645

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.6

18.5

K07

ICPC

Swollen ankles/oedema

2.3

18.5

172

764

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.7

18.5

217

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.1

18.4

103

340

A10BK03

ATC

empagliflozin; oral

2.3

18.4

176

793

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

18.3

576

3903

WX722

NOMESCO Finland

PEEP

2.5

18.3

149

616

M10.0

ICD-10 Finland

Idiopathic gout

2.8

18.3

120

438

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.0

18.3

110

379

SPAT1097

SPAT

Recording of ECG

1.7

18.3

450

2860

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

18.3

202

970

P72

ICPC

Schizophrenia

4.9

18.2

121

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.1

18.1

100

328

C07AG02

ATC

carvedilol; oral

2.1

18.0

216

1072

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.1

18.0

100

329

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.0

18.0

105

357

K56.0

ICD-10 Finland

Paralytic ileus

4.9

18.0

123

TK810

NOMESCO Finland

Hemofiltration

8.4

17.9

A02BC03

ATC

lansoprazole; oral

1.5

17.8

862

6423

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.2

17.7

294

A02BC05

ATC

esomeprazole; systemic

1.4

17.7

1094

8534

WX002

NOMESCO Finland

Sedation and analgesia

1.6

17.7

558

3780

R07.3

ICD-10 Finland

Other chest pain

1.9

17.7

265

1437

N06AX03

ATC

mianserin; oral

2.3

17.7

160

700

H02AA02

ATC

fludrocortisone; oral

5.2

17.7

108

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4.0

17.7

176

H02AB04

ATC

methylprednisolone; systemic

1.7

17.6

428

2708

H05BX01

ATC

cinacalcet; oral

9.8

17.6

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.8

17.6

WX610

NOMESCO Finland

Patient controlled analgesia

9.3

17.6

E66.8

ICD-10 Finland

Other obesity

2.8

17.6

112

403

D11

ICPC

Diarrhoea

1.9

17.6

270

1480

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

17.6

464

3003

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.1

17.5

313

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

17.5

169

763

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

28.9

17.4

SPAT1310

SPAT

Counselling related to known health issue

1.4

17.4

872

6533

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

17.4

461

2990

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.3

17.4

155

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.6

17.4

130

514

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.7

17.3

124

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.1

17.2

107

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.5

17.2

241

R06AE07

ATC

cetirizine; oral

1.4

17.2

1101

8635

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.5

17.2

137

563

C01AA05

ATC

digoxin; systemic

1.7

17.2

414

2613

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.9

17.1

186

L04AD01

ATC

ciclosporin; systemic

4.1

17.1

162

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

9.3

17.1

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

17.1

603

4192

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

17.1

211

1062

ZXA10

NOMESCO Finland

Bilateral

1.5

17.0

573

3940

Z29.0

ICD-10 Finland

Isolation

11.6

17.0

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

8.3

16.9

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.1

16.9

164

R18

ICD-10 Finland

Ascites

3.6

16.9

219

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.4

16.8

137

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.6

16.8

128

N05BE01

ATC

buspirone; oral

3.1

16.6

308

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

16.6

232

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.3

16.6

H02AB07

ATC

prednisone; oral

1.6

16.6

442

2864

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

16.5

144

618

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.5

16.5

126

507

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

16.4

427

2749

R40.2

ICD-10 Finland

Coma, unspecified

5.4

16.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

16.4

118

458

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

16.3

121

477

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

16.3

257

XKD00

NOMESCO Finland

Uroflowmetry

1.5

16.3

565

3908

WW200

NOMESCO Finland

Immunization

3.1

16.3

285

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

16.2

134

561

C09CA06

ATC

candesartan; oral

1.5

16.2

568

3939

196

Kela drug reimbursment

Paricalcitol and cinacalcet

11.2

16.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.8

16.1

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.7

16.1

108

402

SPAT1312

SPAT

General health counselling

1.4

16.1

865

6551

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

16.1

299

TJF80

NOMESCO Finland

Ostomy education

5.0

16.1

103

N05AA01

ATC

chlorpromazine; systemic, rectal

4.5

16.1

125

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.2

16.0

165

770

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

16.0

146

643

C08CA02

ATC

felodipine; oral

1.7

15.9

340

2069

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.2

15.9

162

751

F61.0

ICD-10 Finland

Mixed personality disorders

5.0

15.9

104

N04AA02

ATC

biperiden; systemic

3.5

15.9

214

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.4

15.9

132

555

WX402

NOMESCO Finland

General anaesthesia

1.7

15.9

383

2418

ZZA00

NOMESCO Finland

Split skin graft

2.6

15.9

118

467

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.8

15.8

283

1631

A10AA01

ATC

3.1

15.8

280

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

15.8

950

7343

C09BA02

ATC

enalapril and diuretics; systemic

1.8

15.8

286

1657

N18

ICD-10 Finland

Chronic kidney disease

5.0

15.8

101

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

15.8

335

2038

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

15.7

137

591

A07EA02

ATC

hydrocortisone; rectal

3.2

15.6

260

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

15.6

288

1675

UJF92

NOMESCO Finland

Capsular endoscopy

3.5

15.6

207

J01MA06

ATC

norfloxacin; oral

1.6

15.6

412

2662

X58

ICD-10 Finland

Exposure to other specified factors

1.7

15.6

343

2109

N05CF02

ATC

zolpidem; oral

1.6

15.4

423

2761

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.0

15.4

154

321

Kela drug reimbursment

Paricalcitol and cinacalcet

9.0

15.4

C07AA05

ATC

propranolol; systemic

1.6

15.4

456

3036

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.6

15.3

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.5

15.3

200

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

15.3

110

425

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.7

15.2

186

CKC12

NOMESCO Finland

Photocoagulation of retina

2.4

15.2

127

536

160

Kela drug reimbursment

exenatide

3.9

15.1

157

R1260

NOMESCO Finland

Evaluation of communicative skills

3.4

15.0

219

K51.8

ICD-10 Finland

Other ulcerative colitis

4.6

15.0

111

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.9

15.0

163

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

15.0

237

1310

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.2

15.0

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

15.0

194

999

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

14.9

320

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

14.8

133

583

K50.8

ICD-10 Finland

Other Crohn disease

4.3

14.6

128

R52.9

ICD-10 Finland

Pain, unspecified

1.9

14.6

217

1175

XF404

NOMESCO Finland

Ambulatory ECG

1.8

14.6

270

1572

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

14.5

194

1008

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

14.2

14.5

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.2

14.5

156

742

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

14.4

130

568

SPAT1281

SPAT

Other administrative function

1.9

14.4

225

1239

N06AX26

ATC

vortioxetine; oral

2.4

14.4

127

550

WVA20

NOMESCO Finland

Medicine administration

3.2

14.3

233

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.6

14.3

108

A10BH02

ATC

vildagliptin; oral

3.0

14.3

283

NHQ40

NOMESCO Finland

Amputation of toe

3.1

14.3

250

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

14.3

431

2880

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.0

14.2

271

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

8.6

14.2

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

10.5

14.2

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

14.2

210

1136

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

13.4

14.2

SPAT1138

SPAT

Guidance concerning bowel function

3.3

14.2

224

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

9.7

14.2

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.2

14.1

145

677

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

14.1

172

U05

ICPC

Urination problems other

2.1

14.1

161

787

XG466

NOMESCO Finland

Sleep oxymetry

2.6

14.1

101

393

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

14.0

153

732

N18

ICPC

Paralysis/weakness

3.2

14.0

237

Z43.5

ICD-10 Finland

Attention to cystostomy

5.6

14.0

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

14.0

282

1687

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.1

14.0

243

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

10.9

14.0

J96.0

ICD-10 Finland

Acute respiratory failure

3.6

14.0

179

UJD02

NOMESCO Finland

Gastroscopy

2.1

13.9

168

839

SPAT1265

SPAT

Breathalyser

5.7

13.9

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.0

13.8

265

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

13.8

159

781

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.6

13.6

167

E000003

ATC

2.2

13.6

133

605

H3600, E103

ICD-10 Finland

5.5

13.6

N06DA02

ATC

donepezil; oral

1.8

13.5

259

1524

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

13.5

225

1267

A08

ICPC

Swelling

2.2

13.5

137

634

K20

ICD-10 Finland

Oesophagitis

3.5

13.5

184

S00.0

ICD-10 Finland

Superficial injury of scalp

2.8

13.5

300

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.3

13.5

129

581

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

13.5

139

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

13.4

267

1592

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.7

13.4

159

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

10.1

13.4

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

13.4

338

2157

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.1

13.3

155

762

Y94.0

ICD-10 Finland

Accident at home

3.0

13.3

268

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

5.2

13.3

R5110

SPAT

2.8

13.3

321

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

13.2

478

3326

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

13.2

130

593

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.3

13.2

117

510

A02BA02

ATC

ranitidine; systemic

1.4

13.1

620

4559

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.8

13.1

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.8

13.1

143

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

7.9

13.1

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

7.1

13.0

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.5

13.0

101

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.9

13.0

284

N05BA02

ATC

chlordiazepoxide; systemic

2.7

12.9

314

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

10.1

12.9

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

9.3

12.9

G30.8

ICD-10 Finland

Other Alzheimer disease

2.3

12.9

113

490

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

19.1

12.9

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.9

12.9

135

A10BD07

ATC

metformin and sitagliptin; systemic

2.3

12.9

121

544

N06AX12

ATC

bupropion; oral

2.3

12.9

118

524

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.4

12.9

181

-1

NOMESCO Finland

1.4

12.8

779

5998

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

12.8

317

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

12.8

122

550

JAH01

NOMESCO Finland

Laparoscopy

2.4

12.8

105

440

K22.1

ICD-10 Finland

Ulcer of oesophagus

3.0

12.7

254

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

9.7

12.7

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

12.7

124

567

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.8

12.6

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.1

12.6

118

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.4

12.6

107

457

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

12.6

138

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

5.2

12.5

D10

ICPC

Vomiting

2.2

12.5

123

563

I47.2

ICD-10 Finland

Ventricular tachycardia

2.8

12.5

286

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.9

12.5

263

K02.1

ICD-10 Finland

Caries of dentine

1.3

12.5

1319

11056

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

12.5

149

742

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

12.5

159

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

12.5

327

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

7.3

12.4

A03FA02

ATC

cisapride; oral, rectal

1.7

12.4

259

1568

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.5

12.4

407

D94

ICPC

Chronic enteritis/ulcerative colitis

6.9

12.4

AN3

Balloon angioplasty and metallic stent

2.5

12.3

380

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.3

12.3

117

528

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.3

897

7108

RS222

NOMESCO Finland

3.5

12.3

161

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

12.3

156

R54

ICD-10 Finland

Senility

5.0

12.3

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

12.2

203

1141

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

10.5

12.2

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

524

829

7.16

323.31

1.6

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

867

1971

5.39

307.65

2.3

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1251

3373

5.02

307.65

9.6

4.9

mmol/l

1.1

1.0

2.23

1169

3080

(3021447) Carbon dioxide [Partial pressure] in Venous blood

992

2701

4.60

307.65

6.7

3.6

kpa

5.9

5.8

0.38

950

2607

(3012544) pH of Venous blood

1007

2756

4.60

307.65

6.6

3.6

7.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1313

4098

4.35

307.65

5.9

3.0

mmol/l

0.8

17.54

1234

3751

(3023368) Bacteria identified in Blood by Culture

2054

8216

4.23

307.65

7.1

4.0

—

(3002032) Base excess in Venous blood by calculation

984

2688

4.58

307.65

6.7

3.6

mmol/l

1.8

2.0

0.59

801

2109

(3020779) Urea [Moles/volume] in Serum or Plasma

1022

2379

5.49

307.65

10.7

6.0

mmol/l

12.9

10.5

14.14

967

2238

(3014111) Lactate [Moles/volume] in Serum or Plasma

883

2383

4.51

300.62

8.7

5.7

mmol/l

1.6

1.4

2.53

821

2270

(3024561) Albumin [Mass/volume] in Serum or Plasma

2307

12053

3.29

279.44

9.0

4.4

g/l

32.1

34.9

85.25

2152

11007

(3024354) Oxygen [Partial pressure] in Venous blood

837

2310

4.35

274.91

5.9

3.2

kpa

4.5

0.21

796

2225

(3000991) Gas panel - Venous blood

818

2293

4.26

262.25

11.0

6.8

—

(3026008) Bacteria identified in Urine by Culture

1894

9117

3.13

258.71

5.1

3.3

—

(3003396) Base excess in Arterial blood by calculation

975

3141

3.82

256.49

9.5

6.1

mmol/l

1.2

0.04

784

2383

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1786

8400

3.11

252.72

4.3

2.3

u/l

57.5

58.7

0.35

1683

7692

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

970

3154

3.78

251.21

9.5

6.1

kpa

5.0

5.1

1.42

919

2969

(3027801) Oxygen [Partial pressure] in Arterial blood

969

3153

3.77

250.63

9.5

6.1

kpa

11.2

12.1

6.05

916

2968

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1739

8093

3.10

250.12

3.3

2.0

u/l

283.2

235.7

0.94

1651

7515

(3022948) Iron [Moles/volume] in Serum or Plasma

1167

4339

3.43

244.95

3.8

2.3

umol/l

10.9

12.6

7.35

1064

3974

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1059

3716

3.55

243.47

3.9

2.3

21.1

22.2

1.25

916

3143

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1102

3989

3.47

240.96

3.8

2.2

g/l

2.2

2.3

8.93

1005

3646

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2463

14124

3.08

239.30

9.8

5.7

umol/l

11.8

12.5

1.52

2345

13309

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1624

7537

3.00

230.55

3.1

2.2

mg/l

3.4

3.1

3.95

1417

6373

(3016502) Oxygen saturation in Arterial blood

872

2785

3.76

230.13

10.0

6.4

95.2

95.4

0.35

842

2671

(3023183) Ammonium ion [Moles/volume] in Plasma

341

485

7.62

230.12

2.9

2.5

umol/l

34.6

35.8

0.14

284

398

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1226

4874

3.23

228.21

2.4

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2433

14086

2.99

227.91

14.6

5.7

mmol/l

1.2

17.82

2037

11727

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

569

1344

4.80

225.57

6.4

4.2

mmol/l

23.6

24.1

2.15

509

1201

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2264

12697

2.91

223.54

14.0

5.2

mmol/l

1.2

17.69

2116

11338

(3014576) Chloride [Moles/volume] in Serum or Plasma

975

3436

3.46

220.33

11.8

5.9

mmol/l

103.7

104.5

3.28

953

3364

(3026782) Osmolality of Urine

1336

5698

3.06

218.70

4.6

2.7

mosm/kgh2o

510.2

561.9

16.37

1207

4791

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2026

10981

2.79

209.02

7.3

3.6

ng/l

46.5

67.2

1.48

1724

8110

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

626

1709

4.18

204.94

1.9

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2618

16322

2.90

203.35

10.8

4.2

mmol/l

7.3

6.8

20.76

2529

15189

(3036481) Cortisol [Moles/volume] in Serum or Plasma

673

1989

3.89

196.78

2.4

2.2

nmol/l

390.7

372.2

1.09

617

1790

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

766

2479

3.61

195.70

3.0

2.2

g/l

0.2

1.07

691

2289

(3019309) Folate [Moles/volume] in Red Blood Cells

1357

6210

2.83

190.63

2.3

1.8

nmol/l

1324.1

1175.3

5.53

1073

4615

(3032080) INR in Blood by Coagulation assay

2071

11799

2.64

186.42

16.3

9.9

inr

1.3

0.98

666

3250

(3002173) Hemoglobin [Mass/volume] in Arterial blood

755

2515

3.49

183.61

10.8

6.7

g/l

116.4

120.6

5.62

741

2421

(3019060) Gas panel - Arterial blood

635

1887

3.83

183.47

6.9

4.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

474

1146

4.58

181.02

2.3

1.8

ug/l

2.9

2.4

0.34

435

975

(3027945) Reticulocytes/100 erythrocytes in Blood

925

3539

3.13

178.59

2.8

2.6

1.9

1.7

6.65

799

3089

(3003181) Sodium [Moles/volume] in Urine

239

303

8.34

177.37

2.3

1.3

mmol/l

60.2

66.7

1.12

192

223

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

881

3293

3.17

176.88

2.3

1.7

—

(3009343) pH of Capillary blood

621

1874

3.76

174.98

6.7

3.6

7.4

1.03

115

221

(3002582) Erythrocytes [#/volume] in Urine

1659

8691

2.60

174.68

5.6

3.2

e6/l

65.2

94.4

1.01

1448

6677

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

625

1902

3.73

173.87

6.8

3.6

kpa

5.0

5.2

3.34

589

1730

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

607

1814

3.79

173.42

6.7

3.6

mmol/l

1.5

1.9

1.37

436

1296

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

871

3303

3.12

169.94

2.3

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

568

1690

3.77

162.81

5.7

3.0

g/l

122.6

127.6

5.14

555

1652

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1666

9005

2.50

160.83

4.7

3.0

ng/l

2921.8

1765.8

10.66

1472

7692

(3000850) Epithelial cells [#/volume] in Urine

1282

6159

2.62

158.41

4.3

2.5

e6/l

6.4

5.1

3.11

1167

5353

(3007853) Bacteria identified in Skin by Aerobe culture

833

3198

3.05

158.01

2.4

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

556

1671

3.72

156.74

9.6

6.7

mmol/l

24.2

24.9

2.90

551

1653

(1616796) Gas panel - Central venous blood

315

614

5.50

154.54

5.5

3.6

—

(3018418) pH of Serum or Plasma

1536

8120

2.49

154.08

8.4

3.4

7.4

0.12

397

1569

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

396

944

4.56

153.18

2.4

2.0

ug/l

891.1

651.4

0.36

378

887

(3031040) Bacteria [#/volume] in Urine by Automated count

2731

18724

2.59

152.97

8.5

4.7

e6/l

2160.6

3071.3

0.40

276

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1883

10974

2.41

151.14

4.3

2.7

ug/l

193.1

140.5

7.79

1720

9898

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

595

1923

3.48

149.80

5.5

3.4

ng/l

122.9

91.0

5.93

503

1611

(3018095) Leukocytes [#/volume] in Urine

1756

9965

2.40

149.19

6.8

3.5

e6/l

202.2

123.7

1.51

1489

7169

(3042936) Bacteria identified in Isolate by Culture

912

3794

2.84

148.48

2.9

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

826

3269

2.95

147.44

3.4

4.0

u/l

236.0

244.4

1.32

765

3066

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

477

1349

3.90

146.48

5.3

2.5

1.3

1.2

1.29

477

1342

(3008152) Bicarbonate [Moles/volume] in Arterial blood

558

1759

3.54

145.84

11.5

6.5

mmol/l

24.1

24.6

1.45

541

1642

(3023520) Reticulocytes [#/volume] in Blood

714

2648

3.08

142.73

2.9

2.7

e9/l

70.5

67.2

1.71

569

2019

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

539

1706

3.51

139.71

12.1

7.5

0.7

0.62

533

1699

(3030467) Casts [#/volume] in Urine by Automated count

1473

7955

2.38

137.35

5.3

3.1

e6/l

1.0

0.5

5.13

1270

6051

(3018677) aPTT in Platelet poor plasma by Coagulation assay

936

4098

2.70

136.79

2.7

2.0

30.4

30.1

0.55

905

3940

(3015377) Calcium [Moles/volume] in Serum or Plasma

1672

9559

2.33

136.32

4.5

3.2

mmol/l

2.3

2.4

11.73

1466

8156

(3006315) Basophils [#/volume] in Blood

2100

13217

2.30

136.02

8.0

5.4

e9/l

0.0

0.22

1887

11249

(3027273) Bicarbonate [Moles/volume] in Venous blood

474

1410

3.69

134.81

6.4

2.9

mmol/l

24.6

25.2

2.29

454

1370

(3018405) Lactate [Moles/volume] in Arterial blood

394

1029

4.15

134.79

7.3

3.8

mmol/l

1.5

1.3

1.50

389

1020

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

533

1712

3.45

134.78

12.1

7.4

1.5

1.4

1.39

527

1704

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

461

1346

3.76

134.77

1.8

1.7

g/l

1.6

1.5

2.20

395

1135

(3001604) Monocytes [#/volume] in Blood

2087

13134

2.29

134.76

8.0

5.4

e9/l

0.7

0.6

12.95

1880

11168

(3013115) Eosinophils [#/volume] in Blood

2140

13627

2.29

134.06

8.6

5.6

e9/l

0.2

1.07

1936

11768

(3015235) Bicarbonate [Moles/volume] in Capillary blood

326

748

4.67

131.81

5.1

2.7

mmol/l

23.7

25.1

4.77

300

642

(3019198) Lymphocytes [#/volume] in Blood

2120

13533

2.27

130.84

8.2

5.5

e9/l

1.7

1.9

4.49

1929

11717

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

447

1341

3.64

125.18

7.3

3.5

50.5

48.0

1.20

440

1323

(3025941) Bacteria identified in Stool by Culture

444

1331

3.64

124.45

1.5

1.3

—

(42870588) Differential panel, method unspecified - Blood

1570

9054

2.24

121.87

7.6

5.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

678

2656

2.89

121.39

3.6

2.3

ug/l

5.6

7.2

2.09

564

2240

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1401

7742

2.27

120.32

4.5

3.0

u/l

48.7

35.0

0.64

1321

7272

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1889

11802

2.18

119.16

2.7

2.0

pmol/l

87.6

93.1

5.89

1183

6099

(36304419) Bacteria [Presence] in Urine

1394

7727

2.26

118.44

5.2

3.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

359

976

3.95

115.73

3.8

2.8

u/ml

0.3

0.71

229

549

(3022217) INR in Platelet poor plasma by Coagulation assay

917

4297

2.49

114.00

30.8

28.9

inr

1.4

1.5

0.86

603

(3010421) pH of Blood

311

770

4.31

113.79

6.9

3.8

7.4

2.45

276

638

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

444

1410

3.43

113.49

11.0

7.6

mmol/l

23.9

24.3

1.13

403

1286

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2836

21037

2.33

113.48

13.7

6.8

u/l

90.6

81.0

12.17

2701

19550

(3013650) Neutrophils [#/volume] in Blood by Automated count

2273

15443

2.16

113.38

14.8

8.2

e9/l

4.9

4.2

24.07

2082

13308

(3020630) Protein [Mass/volume] in Serum or Plasma

614

2364

2.90

112.96

2.4

2.3

g/l

63.6

66.2

11.06

554

2094

(3044640) Blood type and Crossmatch panel - Blood

1480

8538

2.19

112.66

3.8

2.4

—

(3012501) Base excess in Blood by calculation

282

655

4.57

111.96

6.9

4.0

mmol/l

2.8

2.5

0.97

191

433

(3027315) Oxygen [Partial pressure] in Blood

283

660

4.55

111.78

6.9

4.0

kpa

8.4

0.25

275

641

(3013290) Carbon dioxide [Partial pressure] in Blood

282

656

4.56

111.74

6.9

4.0

kpa

4.9

5.0

1.19

275

637

(3019069) Monocytes/100 leukocytes in Blood

1934

12420

2.12

110.99

8.7

6.0

8.8

0.05

1829

11462

(3022096) Basophils/100 leukocytes in Blood

1881

11989

2.12

109.71

8.4

5.8

0.6

0.7

7.01

1776

11037

(3006504) Eosinophils/100 leukocytes in Blood

1919

12357

2.11

108.53

8.4

5.7

2.5

2.9

9.06

1810

11350

(3037467) Urinalysis macro (dipstick) panel - Urine

2632

19109

2.20

108.30

7.4

4.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

687

2868

2.70

107.95

3.4

2.8

umol/l

8.5

9.5

0.63

576

2496

(3002030) Lymphocytes/100 leukocytes in Blood

1955

12721

2.09

107.00

8.6

5.8

23.0

27.0

41.96

1841

11666

(3024928) Oxygen saturation in Venous blood

246

532

4.87

106.52

3.5

3.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

331

901

3.93

106.30

7.7

3.9

mmol/l

3.9

0.10

306

854

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

279

679

4.35

104.24

6.0

5.0

mg/l

2.1

1.5

12.05

265

607

(3028626) Oxygen [Partial pressure] in Capillary blood

299

770

4.13

103.62

6.1

3.5

kpa

8.3

0.02

280

711

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1715

10759

2.07

102.14

3.2

2.1

nmol/l

74.2

79.0

8.50

1535

9346

(3035350) Ketones [Presence] in Urine by Test strip

1997

13276

2.05

101.04

6.4

3.8

estimate

0.0

0.00

488

2528

(40767503) Oxygen content in Capillary blood by calculation

261

621

4.44

100.34

3.9

2.2

15.8

16.1

0.43

145

304

(3021601) Nitrite [Presence] in Urine by Test strip

1997

13315

2.04

99.77

8.1

5.1

estimate

0.0

0.50

501

2532

(3020891) Body temperature

383

1202

3.43

99.31

10.4

4.2

—

(3009261) Glucose [Presence] in Urine by Test strip

2013

13503

2.03

98.39

6.4

3.8

estimate

0.0

0.16

482

2473

(3018010) Neutrophils/100 leukocytes in Blood

1899

12522

2.02

96.89

8.2

5.6

61.5

57.9

27.84

1790

11558

(3021960) Folate [Moles/volume] in Serum or Plasma

1217

6871

2.13

94.44

2.0

1.5

nmol/l

18.4

20.4

4.07

1077

5770

(3022313) Gas panel - Capillary blood

405

1371

3.18

92.62

7.5

3.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1296

7542

2.08

92.41

7.0

4.1

estimate

0.0

0.79

441

2416

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1035

5568

2.18

90.32

2.3

1.7

mg/l

1.7

1.4

1.11

839

4238

(3004588) Protein electrophoresis panel - Serum or Plasma

502

1954

2.80

89.31

2.1

2.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

673

3033

2.48

88.91

6.8

3.4

—

(3021901) Oxygen saturation in Capillary blood

228

540

4.43

88.02

4.4

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

869

4413

2.25

87.11

4.8

2.9

e6/l

3.7

2.3

2.38

573

2442

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1856

12466

1.95

86.41

6.2

4.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

207

462

4.68

86.08

6.7

4.6

iu/ml

572.0

4318.5

0.45

(40758558) Short blood count panel - Blood

1167

6734

2.05

83.55

10.8

6.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

568

2429

2.57

83.52

2.5

1.7

1.8

1.5

6.75

468

2115

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1113

6356

2.06

81.67

2.0

1.7

pmol/l

458.5

26428725.9

4.21

912

5146

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

177

365

5.03

80.86

6.6

6.3

mg/l

12.7

11.8

1.43

160

329

(3015736) pH of Urine

1597

10411

1.91

79.28

5.7

3.6

—

5.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

995

5507

2.09

79.08

4.1

3.0

mmol/l

2.5

6.42

862

4785

(3017143) Hepatitis C virus Ab [Presence] in Serum

539

2335

2.52

76.75

2.0

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1168

6916

1.99

76.57

4.1

2.7

umol/l

4760.9

5670.0

0.20

1004

5849

(3033658) Prothrombin time (PT) actual/Normal

1126

6610

2.00

75.47

7.6

3.8

84.2

85.1

0.49

1085

6433

(3000570) Elastase.pancreatic [Mass/mass] in Stool

249

710

3.68

74.31

1.5

1.4

ug/g

245.6

275.4

1.31

151

419

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1578

10433

1.87

73.42

7.0

4.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

528

2315

2.48

73.07

4.3

2.4

u/l

34.1

61.0

0.70

453

1976

(3009508) Creatinine [Moles/volume] in Urine

1314

8228

1.91

72.11

4.2

3.0

mmol/l

6.8

7.5

6.05

1096

6807

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

239

678

3.69

71.83

1.6

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2165

15912

1.83

70.34

5.5

2.9

u/l

83.0

50.3

15.64

2011

14509

(3026250) Tacrolimus [Mass/volume] in Blood

11.24

70.19

54.2

29.6

ug/l

7.0

0.03

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

955

5414

2.02

69.83

6.4

3.6

ng/l

218.0

659.3

1.75

821

4469

(3005719) IgG [Mass/volume] in Serum or Plasma

430

1749

2.64

69.42

2.3

2.8

g/l

10.3

10.7

0.76

391

1587

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

425

1731

2.64

68.38

2.3

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

158

341

4.79

68.34

6.4

4.5

umol/l

348.7

338.6

0.31

135

287

(3016038) Potassium [Moles/volume] in Urine

105

8.55

68.26

2.5

1.3

mmol/l

35.0

36.3

0.16

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

276

891

3.26

67.78

2.2

3.0

mg/l

61.0

52.3

0.16

210

721

(40760892) CBC W Ordered Manual Differential panel - Blood

956

5482

1.99

67.32

6.7

4.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

357

1344

2.83

66.91

1.7

1.9

g/l

1.2

1.5

0.98

329

1208

(3034860) Kappa light chains.free [Mass/volume] in Serum

275

893

3.24

66.87

2.2

3.0

mg/l

58.8

66.7

0.36

208

716

(3020682) Albumin/Creatinine [Ratio] in Urine

1298

8252

1.87

66.84

5.2

3.8

mg/mmol

20.5

7.7

8.47

938

5223

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

228

660

3.61

66.44

1.7

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

268

864

3.26

65.93

2.2

3.0

ratio

1.4

2.5

1.94

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

364

4.54

64.86

5.1

3.2

u/ml

917.3

1694.8

0.35

(40760888) Immunoglobulin light chains.free panel - Serum

227

671

3.53

64.05

2.0

3.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

170

410

4.29

63.95

1.7

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1081

6567

1.90

63.57

3.6

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

199

548

3.77

62.38

1.8

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

188

509

3.83

60.37

1.7

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2514

19792

1.78

60.18

5.4

3.9

mm/h

20.6

13.5

48.54

2317

18018

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

841

4773

1.98

60.13

4.3

2.8

e6/l

1.5

1.2

1.52

544

2776

(3017181) Myelocytes/100 leukocytes in Blood

483

2215

2.35

59.85

4.4

4.1

1.2

0.9

2.07

225

656

(3021589) Normoblasts [#/volume] in Blood

1675

11776

1.75

59.77

20.2

9.3

e9/l

0.0

0.15

1447

9576

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

247

804

3.21

59.72

2.0

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3183

27014

2.04

59.70

42.2

14.5

mg/l

27.7

26.5

1.45

2956

21619

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

344

1348

2.70

59.50

14.6

8.7

—

(3012516) Albumin [Mass/volume] in Urine

1217

7807

1.82

59.40

4.2

3.1

mg/l

296.6

294.4

0.01

896

5010

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

319

1209

2.79

58.84

8.5

4.1

mmol/l

23.9

24.8

4.38

301

1108

(3009445) Proteinase 3 Ab [Units/volume] in Serum

284

1048

2.85

55.01

1.5

u/ml

5.1

21.0

—

(3008295) Osmolality of Serum or Plasma

108

202

5.47

55.01

1.6

1.4

mosm/kgh2o

280.2

283.9

0.64

134

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

492

2367

2.24

54.15

8.7

3.2

mmol/l

1.2

4.35

456

2027

(40761535) Cells panel - Urine sediment

513

2543

2.17

52.32

6.0

3.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

448

2104

2.28

52.16

4.5

4.2

0.2

0.1

0.89

208

605

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

8.70

52.09

3.7

2.7

umol/l

178.4

132.4

0.25

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2455

19606

1.70

51.52

4.7

3.7

pmol/l

15.3

15.0

4.93

2229

17374

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

465

3.69

50.70

1.6

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

637

3490

1.99

49.44

2.1

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

155

5.85

48.90

2.1

1.2

promille

1.4

1.3

0.24

117

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

212

711

3.10

48.64

3.0

2.8

g/l

3.5

0.19

201

669

(3013512) EKG study

1249

8448

1.71

48.61

6.3

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

562

2966

2.05

48.36

2.1

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

231

821

2.93

47.84

1.7

1.6

titre

287.3

220.4

0.21

(3006184) Hemoglobin [Mass/volume] in Capillary blood

198

645

3.18

47.71

3.1

2.1

g/l

123.4

128.6

1.93

169

464

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

134

338

4.07

47.46

1.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

994

6348

1.76

47.29

6.0

3.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

149

408

3.76

47.04

6.8

2.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

557

2963

2.03

46.79

4.3

3.9

ug/l

16.0

24.2

0.79

472

2448

(3019150) Specific gravity of Urine by Refractometry

957

6062

1.77

46.76

6.9

4.2

kg/l

1.0

0.74

113

920

(3002179) Metamyelocytes/100 leukocytes in Blood

419

2011

2.22

46.04

4.2

4.0

0.7

0.6

0.72

152

465

(3037756) Immunofixation for Serum or Plasma

190

620

3.17

45.64

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

380

3.81

45.54

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

149

418

3.67

45.40

1.6

1.4

—

(3036489) Thrombin time

235

871

2.81

45.02

2.6

2.3

23.0

21.4

1.32

208

782

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

272

1090

2.61

44.72

7.5

4.8

1.7

1.6

0.23

261

1021

(3025159) Blasts/100 leukocytes in Blood

408

1962

2.21

44.56

4.5

4.2

0.0

0.3

1.04

173

500

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

215

764

2.92

44.52

1.5

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

169

528

3.30

43.61

3.6

3.5

59.9

58.4

0.71

169

528

(3014765) Yersinia sp identified in Stool by Organism specific culture

214

769

2.89

43.41

1.5

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

157

471

3.43

43.21

3.3

4.0

1.6

1.5

0.15

120

359

(42529406) Shigella sp [Presence] in Stool by Culture

214

773

2.87

42.99

1.5

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

135

368

3.77

42.90

1.6

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

186

628

3.06

42.15

2.5

2.2

ug/min

189.6

99.2

1.27

111

352

(3041096) Erythrocytes [Presence] in Urine by Automated

1057

7053

1.69

42.08

6.2

3.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

193

678

2.94

40.77

1.6

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

262

1081

2.53

40.49

1.8

2.1

g/l

7.7

7.4

1.30

183

787

(3007930) Methemoglobin/Hemoglobin.total in Blood

261

1077

2.53

40.32

7.7

4.8

0.8

0.9

1.17

251

1006

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

192

678

2.93

40.18

1.6

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1079

2.52

40.17

1.8

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

178

4.98

40.08

1.8

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

106

255

4.25

40.00

1.7

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

1078

2.51

39.76

1.8

2.1

g/l

3.9

3.8

0.50

176

754

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

1005

2.56

39.29

1.8

2.1

g/l

3.3

3.1

1.17

177

775

(3042733) HLA Ab [Presence] in Serum

8.85

39.28

5.9

5.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

183

4.84

38.81

1.8

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

168

562

3.08

38.67

1.3

1.2

titre

74.0

93.4

0.62

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

206

773

2.76

38.50

2.0

2.1

g/l

0.0

0.1

1.59

177

695

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

192

696

2.85

38.30

3.1

2.7

88.3

89.5

0.25

179

660

(3048689) Calprotectin [Mass/mass] in Stool

492

2680

1.96

38.16

3.1

2.3

ug/g

207.2

146.8

2.38

394

2061

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.27

38.12

3.1

2.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

145

448

3.32

38.09

2.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

206

779

2.74

37.93

8.3

5.6

mmol/l

1.6

1.4

1.06

178

683

(3027456) Digoxin [Moles/volume] in Serum or Plasma

206

783

2.72

37.55

3.8

3.2

nmol/l

0.9

0.8

1.12

165

587

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

182

650

2.89

37.31

1.5

g/l

1.2

0.05

171

615

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

178

629

2.92

37.20

1.5

g/l

0.2

1.50

166

596

(3011985) Renin [Units/volume] in Plasma

232

4.26

36.89

2.1

1.3

mu/l

115.6

56.1

0.80

205

(40768797) Stomach Pathology biopsy report

582

3395

1.84

36.48

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3181

28188

1.75

36.39

51.3

16.8

mmol/l

138.9

139.7

30.21

3096

27275

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2805

24067

1.61

36.33

5.8

4.4

mu/l

2.1

0.34

2563

21440

(40761536) Microorganisms panel - Urine sediment

450

2417

1.98

36.26

7.3

3.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

172

607

2.92

36.03

1.7

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

194

731

2.74

35.96

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

719

4483

1.74

35.93

1.7

1.4

g/l

2.9

2.6

3.25

483

2603

(3010375) cycloSPORINE [Mass/volume] in Blood

6.33

35.92

28.0

27.2

ug/l

117.8

121.9

0.15

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

225

914

2.55

35.88

2.0

2.2

g/l

0.5

1.3

3.68

186

761

(3037121) Protein [Mass/volume] in Urine

233

964

2.51

35.75

4.6

3.2

g/l

0.4

0.3

1.39

140

376

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

232

960

2.51

35.59

2.4

2.6

—

(40768446) Kidney Pathology biopsy report

7.01

35.58

2.1

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3179

28258

1.73

34.78

51.3

16.9

mmol/l

4.0

7.07

3091

27283

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

409

3.31

34.52

2.2

1.4

u/ml

111.9

121.1

0.35

(3037522) Nuclear Ab [Titer] in Serum

513

2925

1.87

34.45

1.4

1.3

titre

475.6

527.5

0.26

119

627

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

131

408

3.29

33.98

1.7

1.2

u/ml

262.1

271.1

0.13

239

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

137

441

3.18

33.67

1.6

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

166

599

2.85

33.39

3.5

3.2

u/ml

703.9

859.9

0.09

151

546

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.37

32.45

5.3

5.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1028

2.38

32.33

1.9

2.1

g/l

9.8

10.6

1.78

188

840

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

170

632

2.77

32.33

3.3

2.8

214.9

190.2

2.37

157

600

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

188

736

2.63

32.31

2.0

2.1

g/l

0.0

0.50

161

660

(3012565) Volume of 24 hour Urine

5.95

32.10

2.5

2.7

1807.2

1915.8

0.14

(3040151) Glucose [Moles/volume] in Capillary blood

115

344

3.42

31.82

7.1

4.7

mmol/l

7.3

7.0

0.43

105

277

(3052851) Hemolysis interference index of Serum or Plasma

201

824

2.52

31.42

5.7

3.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

206

856

2.49

31.29

2.0

g/l

34.6

37.2

6.08

166

705

(3035637) Corticotropin [Mass/volume] in Plasma

267

3.74

31.21

1.4

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

265

1232

2.24

31.17

2.9

3.0

pmol/l

4.0

4.5

4.14

228

1076

(3028707) Methadone [Presence] in Urine by Screen method

102

288

3.61

30.82

2.5

2.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

183

724

2.60

30.79

2.1

g/l

0.0

0.00

159

657

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

467

2678

1.85

30.60

4.2

2.8

ng/l

377.0

246.4

4.56

427

2420

(40761511) CBC panel - Blood by Automated count

3115

27805

1.64

30.39

38.9

13.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

145

516

2.88

29.93

1.8

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

119

5.19

29.71

2.1

2.6

91.6

97.2

0.58

113

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

135

465

2.97

29.55

4.0

1.7

nmol/l

1.0

0.8

1.51

111

383

(3000494) Fungus identified in Specimen by Culture

485

2861

1.80

28.87

1.7

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

131

451

2.97

28.71

1.5

1.4

g/l

27.4

31.3

2.96

113

404

(44806118)

100

294

3.47

28.44

1.6

1.4

—

(44790047)

100

294

3.47

28.44

1.6

1.4

—

(44790049)

100

294

3.47

28.44

1.6

1.4

—

(44790048)

100

294

3.47

28.44

1.6

1.4

—

(3012441) Differential panel - Pleural fluid

109

340

3.27

28.24

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

108

335

3.29

28.23

1.8

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

4.08

28.22

1.7

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1784

14319

1.46

28.07

3.3

2.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

389

2161

1.89

28.06

4.8

2.5

ml/min/173m2

48.9

63.7

13.50

223

866

(3004716) Salmonella sp identified in Stool by Organism specific culture

245

1152

2.20

28.00

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

130

4.83

27.81

2.0

2.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

21.11

27.66

2.8

1.7

—

(3004451) EKG impression Narrative

106

5.25

27.17

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

107

338

3.23

27.17

1.8

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

106

334

3.24

27.02

1.8

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

106

334

3.24

27.02

1.8

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

106

335

3.23

26.89

1.8

1.3

—

(3019977) pH of Arterial blood

146

4.51

26.84

2.9

2.4

7.4

0.31

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

220

3.79

26.73

1.4

1.3

pmol/l

411.9

265.2

0.42

169

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

342

3.19

26.65

1.8

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

245

1177

2.16

26.52

2.6

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

262

1293

2.10

26.45

2.7

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

10.43

26.23

2.0

2.9

mg/l

37.8

26.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

171

4.15

25.96

1.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

173

4.10

25.57

1.8

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

162

663

2.51

25.42

1.7

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

2502

21616

1.45

25.35

46.5

17.4

14.6

13.8

95.48

2451

21004

(3011648) Oxygen content in Venous blood

179

4.02

25.25

3.2

4.2

10.4

10.8

0.41

179

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

133

4.57

25.19

2.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

133

4.57

25.19

2.1

1.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

5.32

25.10

18.6

10.1

mmol/l

0.7

0.6

0.99

(21494890) Protein electrophoresis panel - 24 hour Urine

265

3.41

24.86

2.0

1.9

—

(40768806) Pleura Pathology biopsy report

104

343

3.09

24.59

1.4

1.6

—

(4035726)

393

2290

1.80

24.20

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

164

699

2.41

23.58

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

743

5140

1.55

23.48

1.4

1.3

u/ml

1.4

1.9

0.51

210

1282

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

109

381

2.91

23.29

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

130

499

2.66

23.28

2.4

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

238

3.45

23.11

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

238

3.45

23.11

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

238

3.45

23.11

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

7.67

22.93

2.6

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

110

391

2.87

22.81

1.2

1.4

—

(3011288) Drugs identified in Urine by Screen method

117

433

2.76

22.50

2.7

2.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

219

3.52

22.35

1.4

1.2

nmol/l

1.4

0.09

192

(3016879) Cocaine [Presence] in Urine

144

593

2.48

22.33

2.4

2.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

195

918

2.18

22.20

2.0

1.7

u/l

37.7

39.4

0.41

165

777

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

143

4.17

22.15

1.5

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

12.29

22.07

3.4

4.8

mg/l

1.8

2.1

0.18

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

5.50

21.93

2.8

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.76

21.93

3.5

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.76

21.93

3.5

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

278

1500

1.92

21.80

1.5

1.4

—

(4198724)

5.59

21.77

2.0

1.9

—

(3017569) Oxygen content in Arterial blood

137

4.21

21.64

2.0

2.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

337

2.96

21.58

1.5

1.6

g/l

0.7

0.9

1.03

254

(3016650) Hepatitis A virus Ab [Presence] in Serum

318

3.00

21.31

1.1

—

(3016750) Collection duration of Urine

144

4.07

21.10

2.0

1.9

min

507.6

487.4

0.55

(44816559) Phosphatidylethanol [Mass/volume] in Blood

105

380

2.81

21.08

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

243

3.30

21.01

1.3

1.1

u/l

75.2

64.4

0.44

147

(3000034) Microalbumin [Mass/volume] in Urine

219

3.43

20.91

4.1

2.7

mg/l

78.2

32.9

0.88

161

(3013727) Leukocytes other/100 leukocytes in Blood

5.05

20.89

3.8

55.7

54.8

0.08

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

210

3.47

20.81

1.3

1.4

u/l

15.9

13.2

1.22

197

(3044889) 12 lead EKG panel

2195

18851

1.38

20.74

5.8

3.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

109

4.54

20.53

3.2

3.6

mg/l

64.4

68.1

0.12

(3000764) Benzodiazepines [Presence] in Urine

146

631

2.37

20.38

2.4

2.0

—

(3011412) CD3 cells [#/volume] in Blood

224

3.35

20.20

1.9

2.5

e9/l

1.0

1.2

0.68

134

(3023419) Bacteria identified in Sputum by Culture

351

2.84

20.07

2.1

2.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

147

3.92

19.71

3.6

3.1

—

(3028300) Cannabinoids [Presence] in Urine

146

641

2.33

19.67

2.4

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

198

984

2.07

19.61

3.1

3.3

u/ml

1359.9

2529.6

0.31

172

830

(3027008) Opiates [Presence] in Urine

145

636

2.33

19.58

2.4

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

136

582

2.39

19.42

1.3

1.5

mg/l

545.0

572.7

0.14

125

549

(3000012) Reticulocyte production index

163

3.72

19.29

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3105

28459

1.48

19.25

18.7

9.8

u/l

24.9

25.2

0.38

2993

27057

(3023199) Leukocytes [#/volume] in Pleural fluid

105

400

2.67

19.14

1.5

1.4

e6/l

1260.8

1935.2

1.07

297

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

212

3.34

19.11

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

212

3.34

19.11

2.1

895.7

596.0

2.07

123

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

125

519

2.46

19.08

1.3

1.5

mmol/l

4.0

3.8

1.36

109

487

(3036782) Glucose [Moles/volume] in Pleural fluid

295

2.96

19.06

1.3

mmol/l

6.8

6.4

0.69

269

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

122

502

2.48

18.99

1.4

1.7

e6/l

500.5

778.3

0.32

105

416

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

122

502

2.48

18.99

1.4

1.6

e6/l

30.9

14.7

0.27

102

400

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

144

3.86

18.64

1.5

1.4

65.9

67.3

0.10

118

(4062490)

207

3.33

18.42

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

155

718

2.21

18.40

1.8

1.6

iu/ml

0.2

12.6

0.76

147

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

114

462

2.51

18.34

1.1

1.2

u/l

25.4

51.1

1.77

394

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

233

3.17

18.32

1.2

u/l

9.1

13.2

2.10

213

(3014271) Vancomycin [Susceptibility]

169

3.59

18.31

3.8

3.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

261

3.03

18.07

3.2

2.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

166

3.59

18.04

3.3

2.4

umol/l

18.7

52.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

329

2.78

17.78

3.2

4.7

—

(3007461) Platelets [#/volume] in Blood

3221

29853

1.49

17.77

57.1

21.2

e9/l

246.9

242.8

2.28

3141

28812

(3022145) Colonoscopy Study observation

423

2727

1.62

17.74

1.6

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

3222

29874

1.49

17.64

57.7

21.4

g/l

124.6

133.9

172.16

3149

29205

(3024731) MCV [Entitic volume]

3221

29863

1.49

17.64

56.9

21.1

92.0

91.3

11.89

3146

29191

(3010813) Leukocytes [#/volume] in Blood

3222

29875

1.49

17.63

57.2

21.2

e9/l

7.5

6.9

45.42

3139

28704

(3027135) IgG subclass 1 [Mass/volume] in Serum

208

3.26

17.60

1.4

1.3

g/l

6.3

6.7

0.41

143

(3028192) IgG subclass 2 [Mass/volume] in Serum

208

3.26

17.60

1.4

1.3

g/l

2.4

2.9

1.71

144

(3024139) IgG subclass 3 [Mass/volume] in Serum

208

3.26

17.60

1.4

1.3

g/l

0.3

0.4

1.29

142

(3009542) Hematocrit [Volume Fraction] of Blood

2664

23900

1.37

17.50

38.0

15.7

36.5

39.0

23.83

1471

15622

(3035941) MCH [Entitic mass]

3220

29864

1.49

17.48

56.8

21.1

30.3

30.4

0.84

3145

29190

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

299

2.85

17.45

1.3

u/l

290.0

455.1

0.60

281

(3026361) Erythrocytes [#/volume] in Blood

3220

29867

1.48

17.44

57.1

21.2

e12/l

4.2

4.4

129.97

3128

28710

(3017354) Segmented neutrophils/100 leukocytes in Blood

311

2.81

17.35

3.1

4.0

64.4

56.4

2.01

193

(3027944) Amphetamines [Presence] in Urine

139

633

2.24

17.22

2.4

2.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.92

16.96

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

131

3.85

16.95

1.1

—

(3039000) Anion gap in Blood

125

550

2.32

16.80

10.9

6.6

mmol/l

12.5

11.4

1.97

117

485

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.67

16.78

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

125

551

2.31

16.73

10.9

6.6

mmol/l

105.3

105.2

0.07

117

486

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

290

2.83

16.66

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

393

2.56

16.65

1.8

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

108

448

2.45

16.56

1.2

1.6

—

(3042631) Mycobacterium sp identified in Specimen

101

408

2.52

16.39

2.5

2.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

374

2.58

16.26

1.5

1.4

e6/l

28851.4

63895.1

0.84

232

(3000093) Morphology [Interpretation] in Blood Narrative

272

2.87

16.24

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

267

2.88

16.19

1.5

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

113

4.02

16.18

1.4

1.1

nmol/l

153.3

140.1

0.58

113

(3051651) Icteric interference index of Serum or Plasma

151

3.54

15.94

6.4

2.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

161

3.45

15.88

2.1

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

128

583

2.24

15.87

2.1

1.8

mg/l

13.8

11.5

1.51

115

533

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

541

3783

1.50

15.72

20.5

7.6

—

(3024932) HLA-DR beta [Type]

4.89

15.66

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

340

2.63

15.66

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

208

3.11

15.63

2.5

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

198

3.17

15.59

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

1538

0.33

15.57

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

129

598

2.20

15.33

1.5

1.3

—

(3024471) HLA-A [Type]

4.75

15.16

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

408

2.44

14.94

4.4

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1650

0.37

14.89

1.4

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

112

3.87

14.73

1.5

1.4

1.0

2.4

1.15

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.27

14.39

9.3

9.5

mmol/l

5.6

6.4

0.29

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

157

3.34

14.34

1.7

1.5

u/l

10.6

6.4

0.42

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

386

2.44

14.29

1.4

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

163

3.28

14.20

1.2

mmol/l

2.5

2.0

1.08

157

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

139

3.48

14.12

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1081

0.24

14.06

1.1

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

239

2.84

13.93

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

117

3.71

13.87

1.2

1.1

iu/ml

4.4

4.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

122

3.64

13.81

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

122

3.64

13.81

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

137

3.46

13.70

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2673

24337

1.32

13.68

8.7

5.7

mmol/mol

43.9

40.1

43.48

2440

21921

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

173

3.15

13.55

1.9

2.5

11.3

13.8

0.59

(21494815) CD4 cells/100 lymphocytes in Specimen

173

3.15

13.55

2.0

2.4

49.6

43.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

11.70

13.53

3.6

4.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

139

697

2.03

13.51

1.8

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

163

866

1.92

13.42

6.6

4.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

146

751

1.98

13.22

1.4

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

177

3.08

13.06

2.2

2.5

nmol/l

20.7

20.0

0.15

167

(3051611) Lipemic interference index of Serum or Plasma

283

2.61

12.96

6.4

2.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

123

3.52

12.91

1.1

1.2

u/l

176.4

317.3

1.14

115

(3044927) Protein electrophoresis panel - Urine

291

2.57

12.77

1.2

1.1

—

(3014891) Appearance of Pleural fluid

5.35

12.76

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

106

492

2.19

12.62

1.4

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

3.44

12.46

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

184

2.96

12.23

1.3

1.2

titre

94.1

186.7

0.88

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

133

3.33

12.16

1.4

1.2

—

(3049717) Cytology report of Urine Cyto stain

207

1221

1.73

12.16

2.5

2.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

190

1096

1.77

12.06

1.2

1.1

titre

311.0

190.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

26.76

12.03

3.5

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.87

11.96

3.8

4.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

3.44

11.91

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

8.03

11.88

2.1

1.6

17.4

21.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

7.42

11.83

2.3

1.7

56.7

54.5

0.07

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

298

2.48

11.69

1.0

1.1

g/l

1.8

1.5

4.93

264

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.35

11.68

2.3

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

163

3.03

11.59

1.6

2.7

e6/l

414.7

541.4

1.14

138

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

22.94

11.56

6.4

1.1

—

(3045788) Cell count panel - Pleural fluid

318

2.42

11.55

1.6

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

159

3.04

11.44

1.9

2.3

e6/l

605.5

680.4

0.33

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.13

11.31

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

268

2.53

11.21

1.6

1.3

nmol/l

0.2

0.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

2.96

11.13

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

4.08

11.12

2.3

1.8

—

(3035880) pH of Pleural fluid

175

2.88

10.84

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.79

10.74

2.1

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

233

2.60

10.68

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

5.27

10.58

1.4

1.6

—

(3019225) pH of Specimen

415

2969

1.45

10.56

9.0

3.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

156

2.97

10.55

2.3

1.9

—

(40757373) Influenza virus identified in Isolate

4.08

10.40

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

237

2.56

10.33

1.6

1.3

nmol/l

—

(3017732) Neutrophils [#/volume] in Blood

267

1753

1.56

10.30

4.2

3.0

e9/l

4.8

4.2

2.03

181

1279

(3009214) Lutropin [Units/volume] in Serum or Plasma

107

547

1.98

9.95

1.5

u/l

11.3

8.8

0.94

439

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

173

2.80

9.89

1.5

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.15

9.88

1.3

1.2

g/l

12.5

14.6

0.43

(3032057) Clostridioides difficile [Presence] in Stool

4.15

9.88

2.5

1.7

—

(3042517) Benzodiazepines panel - Urine

9.26

9.87

1.4

3.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2675

24753

1.27

9.86

39.0

13.6

ml/min/173m2

67.2

76.0

52.52

2380

20295

(3003694) ABO and Rh group [Type] in Blood

867

7038

1.30

9.85

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.74

9.58

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

242

2.46

9.43

1.6

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.88

9.39

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

106

552

1.95

9.37

3.2

2.3

u/l

177.2

3970.8

4.55

225

(3030313) Adrenal Ab [Titer] in Serum

8.59

9.34

1.4

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

147

850

1.76

9.32

1.2

u/ml

0.3

0.8

1.05

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

306

2.28

9.27

3.5

3.7

—

(3052592) Norovirus Ag [Presence] in Stool

4.16

9.16

1.7

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

158

2.81

9.16

1.6

2.7

e9/l

0.1

0.2

2.86

136

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

24.05

8.90

1.0

mmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

243

2.41

8.87

1.5

1.6

u/ml

40.2

27.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

275

2.31

8.80

1.5

1.4

19.1

27.4

1.25

177

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

202

2.55

8.79

2.2

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.02

8.78

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

109

3.14

8.63

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

169

2.68

8.62

1.1

—

(4281824)

228

2.43

8.62

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

158

2.74

8.59

2.3

1.8

u/field

2.4

4.1

0.57

104

(3023410) Appearance of Cerebral spinal fluid

211

2.48

8.53

1.3

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

176

2.63

8.51

2.3

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

268

2.30

8.41

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2752

25734

1.24

8.28

5.6

4.5

mmol/l

6.5

6.0

27.14

2419

22742

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.63

8.27

1.1

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

112

3.05

8.26

1.2

1.5

—

(3018133) Calcium [Moles/volume] in Urine

4.54

8.11

3.2

2.3

mmol/l

2.4

0.00

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.75

8.10

2.3

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

9.11

8.08

1.7

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.48

8.08

2.0

1.7

e6/l

579.0

873.0

0.46

(3005322) IgE [Units/volume] in Serum or Plasma

201

1310

1.56

8.06

1.3

u/ml

402.3

240.4

0.77

184

1213

(3014148) Varicella zoster virus Ab [Titer] in Serum

231

2.36

7.93

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.18

7.92

1.8

2.2

umol/l

17.1

0.01

(40768441) Liver Pathology biopsy report

160

2.64

7.86

1.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

350

2.08

7.77

1.2

1.1

iu/ml

319.8

112.3

0.62

(3017704) Immunofixation for Urine

144

2.73

7.75

1.2

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

140

2.73

7.59

2.1

2.4

—

(3036603) Volume of Urine

129

2.81

7.57

1.6

1526.6

1736.7

0.45

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

120

699

1.74

7.49

2.1

1.7

—

(4306422)

276

2.19

7.46

1.4

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.90

7.42

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.13

7.40

1.0

1.3

ug/l

18.7

553.3

0.90

(3016018) Differential panel - Cerebral spinal fluid

221

2.33

7.30

1.2

1.8

—

(3007733) Chloride [Moles/volume] in Urine

+∞

7.29

3.9

0.0

mmol/l

126.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.61

7.29

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

387

1.98

7.25

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.71

7.12

5.0

4.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.44

7.11

2.1

1.5

e6/l

7655.6

28708.2

0.45

(3000330) Specific gravity of Urine by Test strip

220

1508

1.49

7.01

6.0

3.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.30

6.95

1.2

1.3

14.8

24.4

1.02

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.70

6.90

1.4

1.3

g/l

22.1

28.8

0.81

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.97

6.88

7.6

7.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.97

6.80

2.1

2.0

173.1

158.5

0.29

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

185

2.39

6.76

1.3

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

210

2.30

6.75

1.5

1.4

titre

284.3

287.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.22

6.69

3.3

3.0

umol/l

26.6

28.9

0.53

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.57

6.58

1.4

1.3

14.5

4.6

1.05

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

117

2.75

6.53

1.7

1.4

u/l

5.4

6.3

0.57

100

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

176

2.40

6.52

1.5

1.6

—

(3045414) Leukocytes [Presence] in Urine

174

1155

1.53

6.48

2.7

1.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

124

2.68

6.40

1.5

1.3

nmol/l

1.2

1.0

0.22

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

268

2.11

6.36

1.3

1.1

115.8

111.9

0.29

243

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.25

6.27

1.5

2.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

161

2.44

6.26

1.3

1.5

umol/l

16.0

14.5

0.48

148

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

18.04

6.26

7.6

5.2

umol/l

358.4

427.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.01

6.22

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

298

2.03

6.19

1.2

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.30

6.13

1.4

1.1

91.0

82.2

0.54

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

286

2.04

6.10

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.26

5.95

9.7

7.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.05

5.91

2.1

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

504

1.76

5.91

1.5

1.7

iu/l

4.2

4.0

0.04

151

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

124

2.59

5.87

3.2

3.0

41.4

37.5

0.53

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

136

2.51

5.85

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

2.51

5.85

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

136

2.51

5.85

1.4

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

200

2.21

5.71

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.07

5.62

1.1

97.2

95.6

0.06

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.07

5.62

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

190

2.22

5.53

1.5

1.4

u/l

26.9

23.2

0.21

158

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.25

5.52

1.1

1.0

—

(3022689) Creatine [Moles/volume] in Urine

3.63

5.47

2.1

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

602

1.66

5.39

2.1

1.5

mu/l

393.6

288.0

0.99

545

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

136

2.44

5.36

1.4

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

130

2.47

5.36

1.3

1.1

u/l

15.1

28.9

1.52

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.57

5.32

1.6

1.4

—

(3044007) Cell count panel - Peritoneal fluid

3.19

5.31

2.1

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

156

2.32

5.25

3.6

3.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.65

5.20

7.7

8.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

176

2.23

5.18

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

190

2.17

5.12

3.6

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

306

1.91

5.10

1.4

1.2

u/ml

3.1

3.6

0.14

114

(37021550) Renin [Units/volume] in Plasma --upright

3.57

5.04

1.8

1.2

mu/l

349.2

42.9

0.87

(3019832) Treponema pallidum Ab [Presence] in Serum

225

1658

1.38

4.91

1.8

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.07

4.89

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.22

4.88

1.1

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.34

4.88

1.2

1.4

22.8

22.9

—

(3045424) Erythrocytes [Presence] in Urine

428

1.74

4.87

1.8

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

112

2.51

4.87

1.4

1.8

—

(3045462) Protein/Creatinine [Ratio] in Urine

3.79

4.81

4.6

8.4

g/mol

52.9

85.9

0.42

(3025549) Creatine [Moles/time] in 24 hour Urine

5.01

4.77

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.68

4.74

1.5

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.95

4.71

1.5

1.1

93.5

82.4

0.70

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.95

4.71

1.8

1.1

112.4

100.9

0.56

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

352

1.80

4.67

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

110

2.46

4.54

1.3

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

110

2.46

4.54

1.3

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.01

4.43

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

118

2.38

4.39

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

294

1.85

4.37

1.4

1.2

u/ml

4.8

3.3

0.38

140

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.79

4.28

1.2

1.3

113.4

112.1

0.09

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.90

4.28

7.6

5.7

—

(40768804) Tissue Pathology biopsy report

1172

10541

1.16

4.25

2.4

2.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.04

4.23

1.8

3.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

114

2.38

4.22

1.1

ratio

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.51

4.20

1.9

2.9

12.4

11.6

0.06

(3000475) Leukocytes [#/volume] in Synovial fluid

100

653

1.55

4.14

2.0

1.6

e6/l

31710.0

15727.7

0.98

478

(3001019) Free T4 and TSH panel - Serum or Plasma

808

0.54

4.14

1.8

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

500

0.42

4.14

1.9

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

243

1.90

4.10

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.76

4.08

1.1

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.20

4.05

2.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

149

2.16

4.01

1.1

1.0

mg/l

231.9

273.6

0.50

124

(3010144) Erythrocytes [#/volume] in Synovial fluid

282

1.82

3.96

1.5

1.3

e6/l

58319.8

120731.2

0.67

199

(3022621) pH of Urine by Test strip

242

1867

1.32

3.96

4.4

3.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

212

2765

0.75

3.92

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.64

3.92

2.8

1.5

umol/l

45.6

46.3

0.03

(3024263) Appearance of Synovial fluid

151

2.13

3.89

1.8

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.57

3.88

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.57

3.88

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.29

3.85

1.1

1.0

—

(21494434) Karyotype in Bone marrow

263

1.84

3.85

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

193

1.98

3.82

1.1

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

452

3779

1.22

3.78

1.3

1.2

iu/ml

37.1

39.1

0.11

127

1158

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

758

0.55

3.76

2.9

1.7

mg/l

5.7

4.1

0.21

533

(3034274) Bile acid [Moles/volume] in Serum --fasting

223

1.89

3.72

2.4

2.3

umol/l

22.1

7.8

0.57

158

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.61

3.63

1.5

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.43

3.63

1.7

2.9

33.5

29.6

0.45

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

149

2.09

3.62

1.1

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.26

3.62

1.5

1.2

43.5

46.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.79

3.55

2.4

2.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

157

2.05

3.55

1.1

mg/l

47.8

38.0

0.34

119

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

10.01

3.49

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

204

1571

1.32

3.42

2.5

2.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

133

2.11

3.39

2.3

3.3

mu/l

26.2

26.9

0.02

123

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

174

1.96

3.38

1.0

ng/l

269.6

340.1

0.58

108

(3047189) Immunofixation for 24 hour Urine

120

2.17

3.37

1.5

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

3.37

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.51

3.37

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.51

3.37

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.71

3.35

2.0

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

5.72

3.34

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

175

1.95

3.33

1.1

1.0

ng/l

601.8

700.6

0.62

103

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.92

3.29

2.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

8.58

3.26

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.67

3.22

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.44

3.21

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.58

3.21

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.58

3.19

1.4

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.34

3.19

4.5

2.6

u/field

0.5

0.4

0.23

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.34

3.19

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

303

1.69

3.17

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

111

2.17

3.12

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1205

11053

1.13

3.10

4.5

5.2

ug/l

6.1

4.6

0.22

1019

9817

(4268621)

216

1.81

3.09

2.8

2.2

—

(3021788) Differential panel - Synovial fluid

495

1.53

3.06

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.68

3.05

1.5

1.4

—

(4212803)

3.45

3.04

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

175

1.89

2.99

1.0

ng/l

29.3

47.1

2.27

106

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.41

2.96

1.1

miu/ml

1586.2

1446.7

0.24

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.15

2.93

1.9

1.5

ng/l

153.3

115.9

0.25

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

303

1.66

2.92

2.5

2.2

u/field

1.6

2.1

0.39

(44806071)

4.71

2.91

1.0

1.1

—

(3025315) Body weight

5.39

2.87

3.0

3.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.67

2.86

1.3

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2522

24211

1.12

2.86

4.5

3.8

mmol/l

1.5

1.2

29.95

2225

21466

(4010399)

226

1812

1.26

2.83

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

113

821

1.39

2.82

1.8

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

337

1.61

2.82

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

345

0.43

2.82

1.5

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.06

2.80

1.0

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.06

2.80

1.1

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

144

1.95

2.79

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

3.92

2.77

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

5.01

2.72

1.4

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

153

1.90

2.70

1.1

1.0

mg/l

322.6

289.2

0.96

130

(3034891) Synovial lining cells/100 cells in Synovial fluid

132

1.98

2.69

1.8

1.4

2.3

4.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.98

2.69

1.1

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

723

0.62

2.69

1.4

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

417

3579

1.19

2.68

1.3

1.2

u/ml

12.6

13.3

0.07

150

1328

(3014051) Protein [Presence] in Urine by Test strip

604

1.43

2.63

3.7

2.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.67

2.59

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.90

2.58

1.1

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.30

2.57

1.1

1.2

g/l

0.3

0.65

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

330

1.58

2.57

1.6

1.5

65.0

62.1

0.21

210

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.01

2.56

1.3

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.46

2.54

1.8

1.6

mmol/l

4.6

4.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.04

2.52

1.0

—

(3003338) MCHC [Mass/volume]

2306

22109

1.11

2.48

51.6

19.0

g/l

328.8

331.9

38.89

2259

21800

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.83

2.47

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.38

2.47

2.0

5.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

102

2.06

2.46

1.0

1.2

—

(4027681)

116

1.99

2.45

1.5

1.3

—

(4146454)

264

1.64

2.44

2.5

2.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.95

2.41

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

189

1.75

2.40

1.4

1.3

mmol/l

11.1

11.8

0.19

(3017509) Phencyclidine [Presence] in Urine

4.12

2.36

1.9

1.1

—

(3048879) Bone marrow aspiration report

2.12

2.28

1.2

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.46

2.27

1.1

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2622

25358

1.11

2.26

4.9

4.2

mmol/l

4.2

4.5

49.28

2341

22856

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

163

1.78

2.26

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

163

1.78

2.26

1.7

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

616

1.39

2.23

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.34

2.21

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.56

2.21

7.4

7.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

533

1.42

2.20

1.1

1.3

miu/ml

234.7

225.9

0.04

224

(3044941) Cell count panel - Synovial fluid

428

1.46

2.13

1.8

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

411

0.56

2.13

1.3

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

266

0.45

2.13

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

220

1824

1.22

2.10

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

422

1.45

2.08

3.1

2.2

mg/l

35.9

24.7

0.60

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.98

2.05

1.1

ng/l

3649.8

288.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

315

0.51

2.04

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

314

0.51

2.02

1.8

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

170

1378

1.24

2.02

1.2

iu/ml

103.2

135.3

0.84

484

(4094501)

636

0.66

2.00

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

295

1.53

2.00

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.82

2.00

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

310

0.51

1.96

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.55

1.94

1.2

1.5

umol/24h

227.2

331.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

1.93

1.1

—

(3005033) Fetal Nuchal fold Thickness US

308

0.52

1.92

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.57

1.92

1.0

1.2

u/l

16.2

18.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

583

1.36

1.90

1.6

1.5

iu/l

20.5

24.3

0.56

480

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

212

1.61

1.88

1.4

1.5

nmol/l

0.2

0.3

0.67

174

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.65

1.86

7.4

8.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.21

1.84

2.8

2.3

mg/l

7.5

9.0

0.50

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.17

1.82

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

4.17

1.82

1.2

1.1

—

(3002256) Pathology report gross observation

399

3528

1.15

1.81

1.3

—

(40768800) Prostate Pathology biopsy report

738

0.70

1.80

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.57

1.80

1.8

1.5

—

(3034426) Prothrombin time (PT)

2.09

1.75

1.5

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.50

1.74

1.9

2.1

—

(1002224) Polysomnography panel

728

0.71

1.69

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2678

26076

1.09

1.67

5.3

4.7

mmol/l

2.4

2.7

54.19

2390

23324

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2582

25103

1.09

1.66

4.8

4.1

mmol/l

1.3

1.4

30.75

2287

22451

(3028717) Thiamine [Mass/volume] in Blood

3.16

1.66

1.0

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.58

1.65

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

198

1.57

1.59

1.8

mg/l

5.9

4.3

0.75

186

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.70

1.58

1.9

4.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

491

1.35

1.56

1.3

1.2

—

0.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

114

1.76

1.56

2.7

1.5

g/l

0.8

0.9

2.37

114

(3000492) Spirometry study

248

2145

1.17

1.55

1.5

—

(44806420)

107

1.78

1.54

2.0

2.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

145

1.66

1.53

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

145

1.66

1.53

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

145

1.66

1.53

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.43

1.53

1.9

1.5

pmol/l

44.3

26.8

—

(1761868) Lipid panel - Serum or Plasma

734

7915

0.91

1.53

3.5

2.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

433

1.37

1.52

2.0

1.8

pmol/l

181.9

211.3

1.14

407

(3006270) Folate [Moles/volume] in Blood

266

1.47

1.50

1.4

1.2

nmol/l

328.6

334.4

0.05

212

(3027035) Albumin [Mass/time] in 24 hour Urine

2.86

1.50

1.3

1.4

—

327.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.44

1.47

1.8

2.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

147

1.64

1.47

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

147

1.64

1.47

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

147

1.64

1.47

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

377

0.63

1.43

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

376

0.64

1.42

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

375

0.64

1.40

1.3

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

103

1.75

1.40

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.80

1.37

1.5

1.7

umol/l

5.4

4.3

0.50

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

104

1.73

1.36

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

281

1.43

1.35

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

583

1.29

1.35

1.3

1.2

u/ml

9.2

4.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

654

1.27

1.34

4.2

3.4

mg/l

29.0

30.0

0.11

420

(3020491) Glucose [Moles/volume] in Blood

199

1.51

1.34

2.2

mmol/l

7.7

6.7

0.91

130

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

575

1.29

1.34

1.3

1.2

u/ml

4.4

3.0

—

(3019174) dRVVT (LA screen)

2.78

1.28

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.78

1.28

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

161

1.56

1.28

5.2

17.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

591

6381

0.91

1.27

2.8

3.2

ug/l

0.9

0.8

0.51

411

4486

(3013637) Mi-2 Ab [Presence] in Serum

1.94

1.27

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.94

1.27

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.94

1.27

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.94

1.27

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

243

1.44

1.27

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.00

1.27

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

376

0.66

1.25

1.3

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.91

1.22

2.9

1.2

nmol/l

114.9

127.8

—

(3038026) Centromere Ab [Units/volume] in Serum

212

1.47

1.22

1.3

1.1

—

64.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.63

1.21

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

140

1.57

1.20

1.2

1.4

u/ml

3.5

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.31

1.18

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.31

1.18

1.0

—

34.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

236

0.59

1.16

1.1

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

248

0.60

1.15

1.1

u/ml

15.4

4.9

—

(4024509)

284

1.38

1.12

1.9

1.6

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

127

1.58

1.11

1.6

3.2

u/l

183.2

212.0

1.14

127

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.19

1.08

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.19

1.08

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

218

0.59

1.07

1.2

1.1

u/ml

9.0

6.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

203

1.43

1.05

1.2

1.1

—

98.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

179

0.56

1.05

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

221

2484

0.88

1.04

1.5

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.06

1.02

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

798

0.80

1.01

1.6

1.8

—

(40768443) Skin Pathology biopsy report

142

1226

1.16

0.99

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

516

0.75

0.99

1.6

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.18

0.98

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.18

0.98

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

151

1732

0.87

0.97

1.3

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.86

0.87

1.3

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.00

0.87

16.3

4.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

369

1.28

0.86

2.0

1.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.94

0.84

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.94

0.84

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.94

0.84

1.2

1.0

—

(3028433) Virus identified in Specimen by Culture

1.56

0.84

1.3

1.2

—

(4034850)

102

875

1.17

0.81

19.9

10.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.65

0.81

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

454

0.77

0.81

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

419

1.24

0.79

1.3

1.2

u/ml

55.0

39.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

13.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

5.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

191

1.36

0.76

1.2

1.1

—

2.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.52

0.75

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.70

0.75

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

218

1982

1.11

0.74

2.4

2.0

nmol/l

10.6

12.5

2.33

178

1741

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

131

1156

1.14

0.73

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

312

0.74

0.73

1.1

u/ml

6.4

3.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

108

1.48

0.73

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.72

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

379

3540

1.08

0.71

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.75

0.71

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.55

0.69

1.6

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.51

0.69

2.6

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.53

0.68

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

110

1.46

0.68

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

153

1.37

0.67

5.1

4.3

u/ml

79.2

44.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.63

0.66

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

330

1.24

0.66

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.61

0.65

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

295

1.26

0.65

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

295

1.26

0.65

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

986

0.87

0.62

1.7

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.63

0.62

1.9

3.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

181

1650

1.10

0.61

2.1

2.0

—

(3001729) Color of Synovial fluid

1.67

0.61

1.6

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

14.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.51

0.58

1.8

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.51

0.58

1.5

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

207

0.72

0.56

1.3

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

327

0.79

0.53

1.1

u/ml

2.7

1.4

0.35

172

(3003888) Timothy IgE Ab [Units/volume] in Serum

338

0.80

0.52

1.1

u/ml

10.6

6.1

0.55

196

(3008898) HLA-B27 [Presence]

640

0.86

0.51

1.1

—

(4211845)

154

1.30

0.48

5.0

4.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

465

1.16

0.48

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

571

1.14

0.45

1.1

—

(40768793) Breast Pathology biopsy report

501

0.86

0.43

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.38

0.42

8.3

6.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.43

0.41

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

1.36

0.41

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.52

0.41

1.8

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

709

1.12

0.41

2.2

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.39

0.38

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

330

3449

0.95

0.36

4.8

4.2

33.1

33.0

0.02

232

2221

(3006462) Nitrate [Presence] in Urine

144

1.25

0.35

4.7

4.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.28

0.32

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

132

0.76

0.32

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.31

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

197

0.81

0.31

1.1

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.23

0.29

2.6

4.2

—

41.3

—

(3020650) Glucose [Presence] in Urine

1.25

0.25

1.3

1.5

—

(4015189)

1.23

0.25

1.4

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

193

1849

1.05

0.23

2.2

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

107

1.22

0.21

1.0

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.19

0.21

3.0

2.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3025130) Human papilloma virus identified in Specimen

182

1.15

0.21

1.9

1.8

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

631

6433

0.98

0.20

1.8

1.6

mmol/l

1.6

1.3

9.83

524

5296

(3024316) Viscosity of Plasma

0.00

0.20

0.0

1.7

—

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.17

0.17

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.11

0.17

1.3

1.5

ug/l

17.7

8.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.76

0.17

1.0

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

381

0.92

0.16

1.3

1.2

u/ml

1.3

2.0

0.33

172

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.78

0.14

5.3

1.8

ug/l

9.8

142.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

578

1.06

0.13

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

294

0.92

0.13

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

304

0.92

0.13

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

133

1.13

0.12

1.3

1.2

—

(44813793)

147

0.88

0.11

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

126

0.87

0.11

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

897

8897

1.01

0.09

3.9

4.5

21.6

22.0

0.32

428

4732

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.09

0.08

1.2

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.83

0.08

4.0

6.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.03

0.07

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.82

0.07

5.3

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.03

0.07

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

157

1589

0.99

0.04

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

259

0.96

0.02

1.3

mmol/l

8.2

7.6

0.36

183

(3020874) Milk IgE Ab [Units/volume] in Serum

109

1.01

0.00

1.5

1.1

u/ml

0.2

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

109

1.01

0.00

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.92

0.00

2.6

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.9

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.4

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.94

0.00

1.2

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.2

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.89

0.00

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_VOLUME and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_VOLUME	2.989 [2.56, 3.49]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.148

During the follow-up period (1.1.1998 — 31.12.2019), 10523 out of 18446 females with E4_VOLUME died.

Males

Parameter	HR [95% CI]	p-value
E4_VOLUME	3.723 [3.05, 4.54]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 7499 out of 14569 males with E4_VOLUME died.

Mortality risk

Mortality risk for people of age

years, who have E4_VOLUME.

N-year risk	Females	Males
1	0.25%	0.576%
5	1.584%	4.141%
10	4.033%	9.338%
15	7.718%	16.64%
20	13.341%	27.523%

Relationships between endpoints

↥

Index endpoint: E4_VOLUME – Volume depletion

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Volume depletion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints